                         SEQUENCE LISTING

<110>  DiMarchi, et al.
 
<120>  PRODRUGS WITH PROLONGED ACTION

<130>  32993-229199

<160>  3337  

<170>  PatentIn version 3.5

<210>  1
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  1

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Arg, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  2

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Xaa Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  3
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Asp, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  3

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  4
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  4

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Xaa Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  5
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Asp, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  5

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Xaa Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  6
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Asp, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  6

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  7
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  7

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Xaa Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  8
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Glu, Gln, homoglutamic acid or homocysteic acid

<400>  8

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  9
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  9

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  10
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue

<400>  10

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  11
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  11

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  12
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at position 12 and 16

<400>  12

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  13
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  13

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  14
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (22)..(24)
<223>  Lactam ring between side chains at positions 22 and 24

<400>  14

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  15
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (24)..(28)
<223>  Lactam ring formed between side chains at positions 24 and 28

<400>  15

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Glu Trp Leu Met Lys Thr 
            20                  25                  


<210>  16
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MISC_FEATURE
<222>  (20)..(24)
<223>  Lactam ring between side chains at positions 20 and 24

<400>  16

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  17
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(28)
<223>  Lactam ring between side chains at positions 24 and 28

<400>  17

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Asp Asp Phe Val Glu Trp Leu Met Lys Thr 
            20                  25                  


<210>  18
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  18

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Glu Trp Leu Met Lys Thr 
            20                  25                  


<210>  19
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Variable amino acid

<400>  19

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Xaa 
            20                  25                  30  


<210>  20
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln, Lys, Arg, Orn or Citrulline

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln or Glu

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Asp or Lys

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr or Gly

<400>  20

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Xaa Trp Leu Met Xaa Xaa 
            20                  25                  


<210>  21
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ser, Ala, Gly, N-methyl Ser or aminoisobutyric acid

<400>  21

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  22
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  22

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  23
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  23

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Cys Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  24
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  24

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Cys Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  25
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  25

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  26
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide fragment representing the carboxy terminal 10 
       amino acids Exendin-4

<400>  26

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  27
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide fragment representing the carboxy terminal 8 
       amino acids of oxyntomodulin

<400>  27

Lys Arg Asn Arg Asn Asn Ile Ala 
1               5               


<210>  28
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  28

Lys Arg Asn Arg 
1               


<210>  29
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide fragment representing the carboxy terminal 10 
       amino acids of Exendin-4


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  29

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  30
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  30

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  31
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  31

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  32
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  32

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg 
    


<210>  33
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, homoglutamic acid, cysteic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln or Lys

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln or Glu

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Lys or an acidic amino acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr, Gly or an acidic amino acid

<400>  33

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Xaa Trp Leu Met Xaa Xaa 
            20                  25                  


<210>  34
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, cysteic acid, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln or Lys

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln or Glu

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Asp or Lys

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr or Gly

<400>  34

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Xaa Trp Leu Met Xaa Xaa 
            20                  25                  


<210>  35
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue

<400>  35

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Cys Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  36
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue

<400>  36

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  37
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  2-butyrolactone bound through thiol group of Cys

<400>  37

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  38
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Carboxymethyl group bound through thiol group of Cys

<400>  38

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  39
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue

<400>  39

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Arg Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  40
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Glu or Asp

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Glu or Asp

<400>  40

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Xaa Thr 
            20                  25                  


<210>  41
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation; lactam ring between side chains at positions 12
       and 16

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Glu or Asp

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Glu or Asp

<400>  41

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Xaa Thr 
            20                  25                  


<210>  42
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation; lactam ring between side chains at positions 16
       and 20

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Glu or Asp

<400>  42

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Xaa Thr 
            20                  25                  


<210>  43
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (20)..(24)
<223>  Lactam ring between side chains at positions 20 and 24

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Glu or Asp

<400>  43

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Ser 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Glu Trp Leu Met Xaa Thr 
            20                  25                  


<210>  44
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (24)..(28)
<223>  Lactam ring between side chains at positions 24 and 28

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Glu or Thr

<400>  44

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Glu Trp Leu Met Lys Xaa 
            20                  25                  


<210>  45
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Lys or Glu

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, homoglutamic acid, cysteic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Gln, Glu, Lys, homoglutamic acid, cysteic acid or 
       homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln, Glu or Lys

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln, Lys or Glu

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Lys or an acidic amino acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr, Gly or an acidic amino acid

<400>  45

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Xaa Tyr Leu Xaa Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Xaa Trp Leu Met Xaa Xaa 
            20                  25                  


<210>  46
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln or Lys

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln or Glu

<400>  46

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Xaa Trp Leu Met Asn Thr 
            20                  25                  


<210>  47
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue

<400>  47

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  48
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue

<400>  48

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  49
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue

<400>  49

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Glu Trp Leu Met Lys Thr 
            20                  25                  


<210>  50
<211>  31
<212>  PRT
<213>  Homo sapiens

<400>  50

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg Gly 
            20                  25                  30      


<210>  51
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, homoglutamic acid, cysteic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln, Lys, Arg, Orn, or Citrulline

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Asp, Glu, homoglutamic acid, or homocysteic acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln or Glu

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Lys or an acidic amino acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr, Gly or an acidic amino acid

<400>  51

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Xaa Phe Val Xaa Trp Leu Met Xaa Xaa 
            20                  25                  


<210>  52
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  52

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  53
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Glu, Orn or Nle

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, homoglutamic acid, cysteic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln or Lys

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln or Glu

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Lys or an acidic amino acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr or an acidic amino acid

<400>  53

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Xaa Trp Leu Met Xaa Xaa 
            20                  25                  


<210>  54
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Arg or Gln

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Arg or Ala

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (23)..(23)
<223>  Val or Ile

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln or Ala

<400>  54

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Xaa Xaa Ala Lys Xaa Phe Xaa Xaa Trp Leu Met Asn Thr 
            20                  25                  


<210>  55
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  His, D-His, (Des-amino)His, hydroxyl-His, acetyl-His, homo-His or
       alpha, alpha-dimethyl imidiazole acetic acid (DMIA), N-methyl 
       His, alpha-methyl His, or imidazole acetic acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Ser, D-Ser, Ala, D-Ala, Val, Gly, N-methyl Ser, aminoisobutyric 
       acid (AIB) or N-methyl Ala

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Gln, Glu, Orn or  Nle

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Tyr or Trp

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Lys, Citrulline, Orn or Arg

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, cysteic acid, homoglutamic acid and homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Arg, Gln, Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Arg, Ala, Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln, Lys, Arg, Orn or Citrulline

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Gln, Glu, Asp, Lys, Cys, Orn, homocystein or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (23)..(23)
<223>  Val or Ile

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Ala, Gln, Glu, Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Arg, Citrulline, Orn, Lys or Asp

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr, Gly, Lys, Cys, Orn, homocycsteine or acetyl phenyalanine

<400>  55

Xaa Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Xaa Tyr Leu Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Ala Xaa Xaa Phe Xaa Xaa Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  56
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  His, D-His, (Des-amino)His, hydroxyl-His, acetyl-His, homo-His, 
       DMIA, N-methyl His, alpha-methyl His, or imidazole acetic acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Ser, D-Ser, Ala, D-Ala, Val, Gly, N-methyl Ser, AIB or N-methyl 
       Ala

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Gln, Glu, Orn or  Nle

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, cysteic acid, homoglutamic acid and homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln, Lys, Arg, Orn or Citrulline

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Gln, Glu, Asp, Cys, Orn, homocycstein or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (23)..(23)
<223>  Val or Ile

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Ala, Gln, Glu, Cys, Orn, homocycsteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Lys or Asp

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr, Gly, Lys, Cys, Orn, homocycsteine or acetyl phenyalanine

<400>  56

Xaa Xaa Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Xaa Phe Xaa Xaa Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  57
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  His, D-His, (Des-amino)His, hydroxyl-His, acetyl- His, homo-His, 
       DMIA, N-methyl His, alpha-methyl His, or imidazole acetic acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Ser, D-Ser, Ala, D-Ala, Val, Gly, N-methyl Ser, AIB or N-methyl 
       Ala

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Gln, Glu, Orn or  Nle

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side changes at position 12 and 16

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, cysteic acid, homoglutamic acid and homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln, Lys, Arg, Orn or Citrulline

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Gln, Glu, Asp, Cys, Orn, homocycsteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (23)..(23)
<223>  Val or Ile

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Ala, Gln, Glu, Lys, Cys, Orn, homocysteine or acetyl Phe

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Lys or Asp

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr, Gly, Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<400>  57

Xaa Xaa Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Xaa Phe Xaa Xaa Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  58
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  His, D-His, (Des-amino)His, hydroxyl-His, acetyl-His, homo-His, 
       DMIA, N-methyl His, alpha-methyl His, or imidazole acetic acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Ser, D-Ser, Ala, D-Ala, Val, Gly, N-methyl Ser, AIB or N-methyl 
       Ala

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Gln, Glu, Orn or Nle

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, cysteic acid, homoglutamic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Gln, Glu, Asp, Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (23)..(23)
<223>  Val or Ile

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Ala, Gln, Glu, Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Lys or Asp

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr, Gly, Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<400>  58

Xaa Xaa Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Glu 
1               5                   10                  15      


Arg Arg Ala Lys Xaa Phe Xaa Xaa Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  59
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  His, D-His, (Des-amino)His, hydroxyl-His, acetyl-His, homo-His, 
       DMIA, N-methyl His, alpha-methyl His, or imidazole acetic acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Ser, D-Ser, Ala, D-Ala, Val, Gly, N-methyl Ser, AIB, or N-methyl 
       Ala

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Gln, Glu, Orn or  Nle

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, cysteic acid, homoglutamic acid and homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(24)
<223>  Lactam ring between side chains at position 20 and 24

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Gln, Glu, Asp, Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (23)..(23)
<223>  Val or Ile

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Lys or Asp

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr, Gly, Lys, Cys, Orn, homocysteine or acetyl pheylalanine

<400>  59

Xaa Xaa Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Arg Arg Ala Lys Xaa Phe Xaa Glu Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  60
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  His, D-His, (Des-amino)His, hydroxyl-His, acetyl-His, homo-His, 
       DMIA, N-methyl His, alpha-methyl His, or imidazole acetic acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Ser, D-Ser, Ala, D-Ala, Val, Gly, N-methyl Ser, AIB or N-methyl 
       Ala

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Gln, Glu, Orn or  Nle

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, cysteic acid, homoglutamic acid and homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln, Lys, Arg, Orn, or Citrulline

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Gln, Glu, Asp, Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (23)..(23)
<223>  Val or Ile

<220>
<221>  MISC_FEATURE
<222>  (24)..(28)
<223>  Lactam ring between side chains at position 24 and 28

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr, Gly, Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<400>  60

Xaa Xaa Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Xaa Phe Xaa Glu Trp Leu Xaa Lys Xaa 
            20                  25                  


<210>  61
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  positions 30 to 40 are present only if position 29 is Gly; see 
       specification as filed for detailed description of substitutions 
       and preferred embodiments

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  His, D-His, (Des-amino)His, hydroxyl-His, acetyl-His, homo-His, 
       DMIA, N-methyl His, alpha-methyl His, or imidazole acetic acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Ser, D-Ser, Ala, Val, Gly, N-methyl Ser, Aib, N-methyl, Ala or 
       D-Ala

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Ala or Arg

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Ala, Gln or Cys-PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr-CONH2, Cys-PEG, or Gly

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG or not present

<400>  61

Xaa Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Lys Asp Phe Val Xaa Trp Leu Met Asn Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  62
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<223>  positions 30 to 40 are present only if position 29 is Gly; see 
       specification as filed for detailed description of substitutions 
       and preferred embodiments

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  His, D-His, (Des-amino)His, hydroxyl-His, acetyl-His, homo-His, 
       DMIA, N-methyl His, alpha-methyl His, or imidazole acetic acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Ser, D-Ser, Ala, Val, Gly, N-methyl Ser, AIB0, N-methyl Ala, or 
       D-Ala

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Ala or Arg

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Ala, Gln or Cys-PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr-CONH2, Cys-PEG, or Gly

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG or not present

<400>  62

Xaa Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Xaa Ala Lys Glu Phe Ile Xaa Trp Leu Met Asn Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  63
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln or Lys

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Asp, Lys, Cys, Orn, homocysteine or acetyl phealanine

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln, Lys, Cys, Orn, homocysteine or acetyl phealanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met, Leu or Nle

<400>  63

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Xaa Phe Val Xaa Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  64
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Asp, Glu, homoglutamic acid, cysteic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Gln or Lys

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Gln or Glu

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asn, Lys or Asp

<400>  64

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Xaa Trp Leu Met Xaa Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Pro Pro Pro Ser 
        35              


<210>  65
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide fragment representing the carboxy terminal 10 
       amino acids of Exdendin-4


<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  Cys-PEG

<400>  65

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser Cys 
1               5                   10      


<210>  66
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asp or Asn

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr or Gly

<400>  66

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Xaa Xaa 
            20                  25                  


<210>  67
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asp or Asn

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr or Gly

<400>  67

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Xaa Xaa 
            20                  25                  


<210>  68
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Glucagon Analogue


<220>
<221>  MISC_FEATURE
<222>  (20)..(24)
<223>  Lactam ring between side chains at positions 20 and 24

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Asp or Asn

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr or Gly

<400>  68

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Glu Trp Leu Met Xaa Xaa 
            20                  25                  


<210>  69
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analogue


<220>
<221>  MISC_FEATURE
<222>  (24)..(28)
<223>  Lactam ring between side chains at positions 24 and 28

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Thr or Gly

<400>  69

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Glu Trp Leu Met Lys Xaa 
            20                  25                  


<210>  70
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  70

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  71
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  71

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  72
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  72

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  73
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  73

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  74
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  74

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  75
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  75

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  76
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  76

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  77
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  77

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  78
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  78

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  79
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  79

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  80
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  80

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  81
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  81

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  82
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  82

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  83
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  83

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  84
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  84

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  85
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  85

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  86
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  86

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  87
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  87

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  88
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  88

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  89
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  89

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  90
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  90

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  91
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  91

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  92
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  92

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  93
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  c-term amidation

<400>  93

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  94
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  94

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  95
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  95

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  96
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  96

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  97
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  97

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  98
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  98

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  99
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  99

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  100
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  100

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  101
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  101

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  102
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  102

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  103
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  103

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  104
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  c-term amidation

<400>  104

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  105
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  105

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  106
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  106

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  107
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  107

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  108
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisebutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  108

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  109
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  109

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  110
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  110

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  111
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  111

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  112
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  112

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  113
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  113

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  114
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  114

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  115
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  115

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  116
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  116

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  117
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  117

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  118
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  118

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  119
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  119

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  120
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  120

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  121
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  121

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  122
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  122

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  123
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  123

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  124
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  124

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  125
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  125

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  126
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  126

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  127
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  127

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  128
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  128

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  129
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  129

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  130
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  130

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  131
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  131

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  132
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  132

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  133
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  133

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  134
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  134

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  135
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  135

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  136
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  136

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  137
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  137

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  138
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  138

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  139
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  139

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  140
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  140

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  141
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  141

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  142
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  142

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  143
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  143

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  144
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  144

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  145
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  145

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  146
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  146

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  147
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  147

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  148
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  148

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  149
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  149

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  150
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  150

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  151
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  151

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  152
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  152

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  153
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  153

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  154
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  154

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  155
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  155

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  156
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  156

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  157
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  157

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  158
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  158

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  159
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  159

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  160
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  160

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  161
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  161

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  162
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  162

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  163
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  163

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  164
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  164

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  165
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  165

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  166
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  166

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  167
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  167

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  168
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  168

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  169
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  169

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  170
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  170

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  171
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  171

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  172
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  172

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  173
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  173

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  174
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  174

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  175
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  175

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  176
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  176

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  177
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  177

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  178
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  178

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  179
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  179

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  180
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  180

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  181
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  181

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  182
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  182

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  183
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  183

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  184
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  184

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  185
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  185

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  186
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  186

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  187
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  187

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  188
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  188

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  189
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  189

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  190
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  190

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  191
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  191

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  192
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  192

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  193
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  193

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  194
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  194

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  195
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  195

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  196
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  196

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  197
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  197

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  198
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  198

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  199
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  199

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  200
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  200

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  201
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  201

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  202
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  202

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  203
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  203

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  204
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  204

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  205
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  c-term amidation

<400>  205

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  206
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  206

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  207
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  207

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  208
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  208

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  209
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  209

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  210
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  210

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  211
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  211

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  212
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  212

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  213
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  213

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  214
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  214

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  215
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  215

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  216
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  216

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  217
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  217

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  218
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  218

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  219
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  219

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  220
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  220

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  221
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  221

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  222
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  222

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  223
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  223

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  224
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  224

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  225
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  225

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  226
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  226

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  227
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  227

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  228
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  228

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  229
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  229

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  230
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  230

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  231
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation; lactam ring between side chains at positions 12
       and 16

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  231

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  232
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  232

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  233
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  233

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  234
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  234

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  235
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  235

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  236
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  236

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  237
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  237

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  238
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  238

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  239
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analog


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  239

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  240
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  240

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  241
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  241

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  242
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  242

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  243
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  243

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  244
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  244

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  245
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  245

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  246
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  246

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  247
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  247

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  248
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  248

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  249
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  249

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  250
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  250

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  251
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  251

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  252
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  252

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  253
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  253

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  254
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  254

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  255
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  255

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  256
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  256

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  257
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  257

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  258
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  258

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  259
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  259

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  260
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chrains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  260

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  261
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation; lactam ring between side chains at positions 12
       and 16

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  261

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  262
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  262

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  263
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  263

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  264
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  264

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  265
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  265

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  266
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring betwee side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  266

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  267
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  267

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  268
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  268

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  269
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring betwee side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  269

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  270
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring betwee side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  270

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  271
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  271

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  272
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  272

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  273
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  273

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  274
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  274

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  275
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  275

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  276
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  276

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  277
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  277

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  278
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  278

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  279
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  279

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  280
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  280

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  281
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  281

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  282
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  282

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  283
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  283

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  284
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  284

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  285
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  285

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  286
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  286

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  287
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chain at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  287

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  288
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  288

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  289
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  289

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  290
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  290

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  291
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  291

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  292
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  292

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  293
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  293

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  294
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  294

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  295
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  295

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  296
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  296

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  297
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  297

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  298
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  298

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  299
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  299

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  300
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  300

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  301
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  301

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  302
<211>  29
<212>  PRT
<213>  Artificial Sequencce

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  302

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Gly Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  303
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  303

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Gly Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  304
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  304

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Gly Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  305
<211>  29
<212>  PRT
<213>  Artificial Sequencce

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (des-amino)His

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  305

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Gly Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  306
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  306

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Gly Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  307
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  307

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Gly Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  308
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  308

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  309
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  309

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  310
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  310

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  311
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chain at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  311

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  312
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  312

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  313
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  313

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  314
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  314

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  315
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between seide chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  315

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  316
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  316

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  317
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 adn 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  317

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  318
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  318

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  319
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  319

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  320
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  320

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  321
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at position 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  321

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  322
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  322

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  323
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  323

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  324
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at position 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  324

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  325
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  325

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  326
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  326

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  327
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  327

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  328
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  328

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  329
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  329

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  330
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  330

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  331
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  331

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  332
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  332

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  333
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  333

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  334
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  334

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  335
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chainst at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  335

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  336
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  336

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  337
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  337

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  338
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam right between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  338

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  339
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  339

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  340
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  340

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  341
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  341

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly 
            20                  25                  


<210>  342
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  342

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  343
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  343

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  344
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  344

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  345
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  345

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  346
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  346

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  347
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  347

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  348
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  348

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  349
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  349

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  350
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  350

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  351
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  351

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  352
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  352

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  353
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  353

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  354
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  354

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  355
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  355

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  356
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  356

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  357
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  357

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  358
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  358

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  359
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  359

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  360
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  360

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  361
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  361

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  362
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  362

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  363
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  363

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  364
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  364

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  365
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  365

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  366
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  366

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  367
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  367

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  368
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  368

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  369
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  369

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  370
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  370

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  371
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  371

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  372
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  372

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  373
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Cys-PEG

<400>  373

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  374
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  374

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  375
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  375

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  376
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  376

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  377
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  377

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  378
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  378

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  379
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  379

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  380
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  380

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  381
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation; lactam ring between side chains at positions 16
       and 20

<400>  381

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  382
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  382

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  383
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  383

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  384
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  384

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  385
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  385

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  386
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  386

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  387
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  387

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  388
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  388

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  389
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  389

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  390
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  390

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  391
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  391

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  392
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be any naturally occurring amino acid

<400>  392

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  393
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  393

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  394
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  394

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  395
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  395

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  396
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  396

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  397
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  397

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  398
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  398

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  399
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  399

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  400
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  400

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  401
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  401

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  402
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  402

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  403
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  403

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  404
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  404

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  405
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  405

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  406
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  406

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  407
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  407

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  408
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  c-term amidation

<400>  408

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  409
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  409

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  410
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  410

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  411
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  411

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  412
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  412

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  413
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  413

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  414
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  414

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  415
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  415

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  416
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  416

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  417
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  417

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  418
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  418

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  419
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  419

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  420
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  420

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  421
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  421

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  422
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  422

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  423
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  423

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  424
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  424

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  425
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  425

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  426
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  426

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  427
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  427

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  428
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  428

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  429
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  429

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  430
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  430

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  431
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  431

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  432
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  432

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  433
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  433

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  434
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  434

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  435
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  435

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  436
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  436

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  437
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<223>  Lactam ring between side chains at positions 16 and 20

<400>  437

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  438
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  438

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  439
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  439

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  440
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  440

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  441
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  441

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  442
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  442

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  443
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  443

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  444
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  444

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  445
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  445

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  446
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  446

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  447
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<223>  Lactam ring between side chains at positions 12 and 16

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  447

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  448
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  448

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  449
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  449

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  450
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  450

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  451
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  451

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  452
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  C-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  452

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  453
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  453

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  454
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  454

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  455
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<400>  455

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  456
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  456

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  457
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  (Des-amino)His

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  457

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  458
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  458

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  459
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  459

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  460
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  460

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  461
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  461

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  462
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  462

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  463
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  463

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  464
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  464

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  465
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  465

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  466
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at postions 12 and 16

<400>  466

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  467
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  467

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  468
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  468

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  469
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<400>  469

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  470
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  470

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  471
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  471

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  472
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  472

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  473
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  473

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  474
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  474

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  475
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  475

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  476
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  476

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  477
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  477

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  478
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  478

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  479
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  479

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  480
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  480

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  481
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  481

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  482
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  482

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Glu Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  483
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<400>  483

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  484
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam ring between side chains at positions 12 and 16

<400>  484

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  485
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<400>  485

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  486
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  486

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  487
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Cys-PEG

<400>  487

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Cys 
            20                  25                  


<210>  488
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG

<400>  488

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  489
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG

<400>  489

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  490
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  490

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  491
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  491

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  492
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  492

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  493
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  493

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Cys 
            20                  25                  


<210>  494
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  494

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  495
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG

<400>  495

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  496
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  496

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  497
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  497

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  498
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  498

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr Ala 
            20                  25                  30  


<210>  499
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  499

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Cys 
            20                  25                  


<210>  500
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG

<400>  500

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  501
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG

<400>  501

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  502
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  502

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  503
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  503

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  504
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  504

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  505
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha-Dimethyl Imidiazole Acetic Acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  505

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  506
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha-Dimethly Imidiazole Acetic Acid

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha-Dimethly Imidiazole Acetic Acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Cys-PEG

<400>  506

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Cys 
            20                  25                  


<210>  507
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG

<400>  507

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  508
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG

<400>  508

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  509
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  509

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  510
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  510

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  511
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  511

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  512
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Cys-PEG

<400>  512

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Cys 
            20                  25                  


<210>  513
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  513

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  514
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  514

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  515
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  515

Gly Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10      


<210>  516
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Cys-PEG

<400>  516

Gly Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser Cys 
1               5                   10          


<210>  517
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  517

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  518
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  518

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  519
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethly Imidiazole Acetic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  519

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  520
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Cys-PEG

<400>  520

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Cys 
            20                  25                  


<210>  521
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  521

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  522
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  522

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  523
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  523

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  524
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  524

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Val Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  525
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  525

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  526
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  526

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  527
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  527

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Gly 
            20                  25                  30  


<210>  528
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains at positions 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  528

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  529
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  529

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  530
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Alpha, Alpha Dimethyl Imidiazole Acetic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  530

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  531
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG

<400>  531

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  532
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (41)..(41)
<223>  Cys-PEG

<400>  532

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys Cys 
        35                  40      


<210>  533
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  c-term amidation

<400>  533

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  534
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera 2 AIB2 K10-C8 Cys 24-40K

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C8 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  534

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  535
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera 2 AIB2 K10-C14 Cys 24-40K

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C14 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  535

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  536
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera 2 AIB2 K10-C16 Cys24-40K

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  536

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  537
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera 2 AIB2 K10-C18 Cys24-40K

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C18 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  537

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  538
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera 2 K10-C18 Cys24-40K

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C18 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  538

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  539
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-C18 Cys24-40K

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C18 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  539

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  540
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-W-C18

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to Trp residue comprising a C18 fatty acid

<400>  540

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  541
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-W-C16 Cys24-40K

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to Trp residue comprising a C16 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  541

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  542
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-C16

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acid

<400>  542

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  543
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-C16

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to Trp residue comprising a C16 fatty acid

<400>  543

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  544
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-C18

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C18 fatty acid

<400>  544

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  545
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  545

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  546
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-W-C16 Cys 24-40K

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to Trp residue comprising C16 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  546

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  547
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-C18 Cys24-40K

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C18 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  547

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  548
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-C18 Cys24-40K

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to Trp residue comprising a C18 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  548

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  549
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon E16 K20 K10-C16 amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to Glu residue comprising a C16 fatty acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  549

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  550
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera 2 truncated by one amino acid

<400>  550

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn 
            20                  25              


<210>  551
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera 2 truncated by two amino acids

<400>  551

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met 
            20                  25          


<210>  552
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  aa 1-28, E16 K20 C-terminal amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  552

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn 
            20                  25              


<210>  553
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  aa 1-27 E16 K20 C-terminal amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<400>  553

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Lys Met 
            20                  25          


<210>  554
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Norleucine

<400>  554

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  555
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridging side chains at positions 16 and 20

<400>  555

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  556
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera 2 with AIB at 16

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric acid

<400>  556

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  557
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric acid

<400>  557

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  558
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to Trp residue comprising a C16 fatty acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  558

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  559
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutric Acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to Trp residue comprising a C16 fatty acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutric Acid

<400>  559

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  560
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to Trp residue comprising a C16 fatty acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<400>  560

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  561
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to Trp residue comprising a C16 fatty acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Aminoisobutyric acid

<400>  561

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  562
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric acid

<400>  562

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  563
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<400>  563

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  564
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<400>  564

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  565
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  565

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  566
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via beta-Ala-beta-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  566

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  567
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via 6-aminohexanoic acid 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  567

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  568
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via Leu-Leu spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  568

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  569
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via Pro-Pro spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  569

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  570
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  570

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  571
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  571

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  572
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  572

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  573
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  573

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  574
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  574

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  575
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  575

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  576
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  576

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  577
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group

<400>  577

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  578
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<400>  578

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  579
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  AA-C16 Glucagon Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via Ala-Ala spacer

<400>  579

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  580
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera 2, AIB2, Lys10, Cys24-PEG

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  580

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  581
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide dS2E16K20K30-C14 Gluc Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C14 fatty acyl group

<400>  581

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  582
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide dS2K10(C14)E16K20-Gluc Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group

<400>  582

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  583
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide dS2E16K20K30-C16 Gluc Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C16 fatty acyl group

<400>  583

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  584
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide dS2K10(C16)E16K20-Gluc Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group

<400>  584

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  585
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide Chimera 2-AIB2-K10-acylated

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  585

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  586
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide Chimera 2-AIB2-K30-acylated

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C18 fatty acyl group

<400>  586

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  587
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  DMIA

<400>  587

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  588
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  DMIA

<220>
<221>  MOD_RES
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<400>  588

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  589
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<400>  589

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  590
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  590

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  591
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is a Glutamine analog

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Norleucine

<400>  591

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  592
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is a Glutamine analog

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  592

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  593
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Norleucine

<400>  593

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  594
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetamidomethyl-cysteine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Norleucine

<400>  594

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  595
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Norleucine

<400>  595

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  596
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is carbamoyldiaminopropanoic acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Norleucine

<400>  596

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  597
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Methylglutamine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Norleucine

<400>  597

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  598
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Methionine sulfoxide

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Norleucine

<400>  598

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  599
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Acetylornithine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Norleucine

<400>  599

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  600
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutryic Acid

<400>  600

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  601
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutyric Acid

<400>  601

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  602
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Methylglutamine

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutyric Acid

<400>  602

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  603
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutryic Acid

<400>  603

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Glu 
            20                  25                  


<210>  604
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutyric Acid

<400>  604

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  605
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutryic Acid

<400>  605

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ser Asp Phe Val Ser Trp Leu Leu Asp Glu 
            20                  25                  


<210>  606
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutryic Acid

<400>  606

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Thr Asp Phe Val Thr Trp Leu Leu Asp Glu 
            20                  25                  


<210>  607
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<400>  607

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  608
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  DMIA

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<400>  608

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  609
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  DMIA

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<400>  609

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  610
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  610

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  611
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  611

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  612
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  612

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  613
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group

<400>  613

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  614
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group

<400>  614

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  615
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to a C18 fatty acyl group

<400>  615

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  616
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<400>  616

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  617
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  617

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  618
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  618

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  619
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via di peptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<400>  619

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  620
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covelently bound to C16 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<400>  620

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  621
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<400>  621

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  622
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<400>  622

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  623
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  beta-Ala-beta-Ala - C16 Glucagon Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via beta-Ala-beta-Ala spacer

<400>  623

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  624
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera-2 Aib2C24Mal40KPEG

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with a maleimide-activated PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  624

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  625
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera-2 Aib2E16K20lactamC24Mal40KPEG

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of the amino acids at positions 
       16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with a maleimide-activated PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  625

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  626
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Aib2E16K20lactamC24amideMal40KPEG

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with a maleimide-activated PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  626

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  627

<400>  627
000

<210>  628
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Dmia1E16K20lactamC24Mal40KPEG

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with a maleimide-activated PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  628

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  629
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Dmia1E16K20lactamC24Mal40KPEG

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with a maleimide-activated PEG

<400>  629

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  630
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Dmia1E16K20lactamC24thioether40KPEG

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at position 16 and
       20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  630

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  631
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Chimera2 Aib2E3C24-Thioether40K PEG(NOF)

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  631

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  632
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  632

Xaa Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  633
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Aib2Aib16C24K10(rErE-C16) C24PEG40K amide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  633

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  634
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Aib2Aib16K10(AA-C14)C24PEG40K TE amide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  634

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  635
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Aib2Aib16K10(AA-C16) amide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  635

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  636
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Aib2Aib16K10(rErE-C16) amide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  636

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  637
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  637

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  638
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  638
caaggtccag ggaggttgtg                                                   20


<210>  639
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  639
ccaaaggtaa gctgtccata agga                                              24


<210>  640
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  640
ctctcccaag agtcacatgt cc                                                22


<210>  641
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  641
caataactcg gtcccctaca ac                                                22


<210>  642
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  642

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  643
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<400>  643

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  644
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<400>  644

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  645
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<400>  645

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  646
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<400>  646

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  647
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group

<400>  647

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  648
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<400>  648

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  649
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<400>  649

His Xaa Gln Gly Thr Phe Ile Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  650
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<400>  650

His Xaa Gln Gly Thr Phe Ile Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  651
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<400>  651

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  652
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<400>  652

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  653
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<400>  653

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Lys 
            20                  25                  


<210>  654
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<400>  654

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Lys 
            20                  25                  


<210>  655
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  655

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  656
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  656

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  657
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  657

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  658
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutyric Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  658

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  659
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  659

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  660
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  660

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  661
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<400>  661

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  662
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide dS2E16K20K30-C14 Gluc Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C14 fatty acyl group

<400>  662

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  663
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide dS2K10(C14)E16K20-Gluc Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group

<400>  663

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  664
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide dS2E16K20K30-C16 Gluc Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C16 fatty acyl group

<400>  664

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  665
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide dS2K10(C16)E16K20-Gluc Amide

<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group

<400>  665

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  666
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group

<400>  666

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  667
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group

<400>  667

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  668
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to a C18 fatty acyl group

<400>  668

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  669
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<400>  669

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  670
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Aib2Aib16C24K10(rErE-C16) C24PEG40K amide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  670

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  671
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Aib2Aib16K10(rErE-C16) amide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  671

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  672
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<400>  672

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  673
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<400>  673

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  674
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<400>  674

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  675
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<400>  675

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  676
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<400>  676

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  677
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<400>  677

His Xaa Gln Gly Thr Phe Ile Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  678
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<400>  678

His Xaa Gln Gly Thr Phe Ile Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  679
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<400>  679

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  680
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<400>  680

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  681
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<400>  681

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Lys 
            20                  25                  


<210>  682
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<400>  682

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Lys 
            20                  25                  


<210>  683
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  683

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  684
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  c-term amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  684

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  685

<400>  685
000

<210>  686

<400>  686
000

<210>  687

<400>  687
000

<210>  688

<400>  688
000

<210>  689

<400>  689
000

<210>  690

<400>  690
000

<210>  691

<400>  691
000

<210>  692

<400>  692
000

<210>  693

<400>  693
000

<210>  694

<400>  694
000

<210>  695

<400>  695
000

<210>  696

<400>  696
000

<210>  697

<400>  697
000

<210>  698

<400>  698
000

<210>  699

<400>  699
000

<210>  700

<400>  700
000

<210>  701
<211>  29
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  701

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  702
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analog


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<400>  702

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  703
<211>  31
<212>  PRT
<213>  Homo sapiens

<400>  703

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg Gly 
            20                  25                  30      


<210>  704
<211>  30
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  AMIDATION

<400>  704

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  705
<211>  28
<212>  PRT
<213>  Homo sapiens

<400>  705

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly 
            20                  25              


<210>  706
<211>  37
<212>  PRT
<213>  Homo sapiens

<400>  706

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  707
<211>  42
<212>  PRT
<213>  Homo sapiens

<400>  707

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Asp Trp Lys His Asn Ile Thr Gln 
        35                  40          


<210>  708
<211>  33
<212>  PRT
<213>  Homo sapiens

<400>  708

His Ala Asp Gly Ser Phe Ser Asp Glu Met Asn Thr Ile Leu Asp Asn 
1               5                   10                  15      


Leu Ala Ala Arg Asp Phe Ile Asn Trp Leu Ile Gln Thr Lys Ile Thr 
            20                  25                  30          


Asp 
    


<210>  709
<211>  49
<212>  PRT
<213>  Homo sapiens

<400>  709

Tyr Leu Tyr Gln Trp Leu Gly Ala Pro Val Pro Tyr Pro Asp Pro Leu 
1               5                   10                  15      


Glu Pro Arg Arg Glu Val Cys Glu Leu Asn Pro Asp Cys Asp Glu Leu 
            20                  25                  30          


Ala Asp His Ile Gly Phe Gln Glu Ala Tyr Arg Arg Phe Tyr Gly Pro 
        35                  40                  45              


Val 
    


<210>  710
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide fragment representing the carboxy terminal 10 amino acids
       of Exendin-4

<400>  710

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  711
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide fragment representing the carboxy terminal 10 amino acids
       of Exendin-4


<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  AMIDATION

<400>  711

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  712
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide fragment representing the carboxy terminal 10 amino acids
       of Exendin-4


<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  Pegylation

<400>  712

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser Cys 
1               5                   10      


<210>  713
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide fragment representing the carboxy terminal 13 amino acids
       of GIP peptide

<400>  713

Lys Gly Lys Lys Asn Asp Trp Lys His Asn Ile Thr Gln 
1               5                   10              


<210>  714
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide fragment representing the carboxy terminal 8 amino acids 
       of oxyntomodulin

<400>  714

Lys Arg Asn Arg Asn Asn Ile Ala 
1               5               


<210>  715
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  C-terminal amide

<400>  715

His Thr Arg Gly Thr Phe 
1               5       


<210>  716
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-histidine

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-threonine

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  d-arginine

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  d-threonine

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  d-phenylalanine

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  C-terminal amidation

<400>  716

Xaa Xaa Xaa Gly Xaa Xaa 
1               5       


<210>  717
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glucagon analogue


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  pegylation

<400>  717

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  718
<211>  39
<212>  PRT
<213>  Heloderma suspectum

<400>  718

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  719
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  719

Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr Arg Lys Val Leu Gly Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Met Ser Arg 
            20                  25                  


<210>  720
<211>  28
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  AMIDATION

<400>  720

His Ser Asp Ala Val Phe Thr Asp Asn Tyr Thr Arg Leu Arg Lys Gln 
1               5                   10                  15      


Met Ala Val Lys Lys Tyr Leu Asn Ser Ile Leu Asn 
            20                  25              


<210>  721
<211>  27
<212>  PRT
<213>  Homo sapiens

<400>  721

His Ser Asp Gly Ile Phe Thr Asp Ser Tyr Ser Arg Tyr Arg Lys Gln 
1               5                   10                  15      


Met Ala Val Lys Lys Tyr Leu Ala Ala Val Leu 
            20                  25          


<210>  722
<211>  27
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  AMIDATION

<400>  722

His Ala Asp Gly Val Phe Thr Ser Asp Phe Ser Lys Leu Leu Gly Gln 
1               5                   10                  15      


Leu Ser Ala Lys Lys Tyr Leu Glu Ser Leu Met 
            20                  25          


<210>  723
<211>  27
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  AMIDATION

<400>  723

His Ser Asp Gly Thr Phe Thr Ser Glu Leu Ser Arg Leu Arg Glu Gly 
1               5                   10                  15      


Ala Arg Leu Gln Arg Leu Leu Gln Gly Leu Val 
            20                  25          


<210>  724
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys residue linked to 40kDa PEG via maleimide

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  724

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr Asn 
            20                  25                  30  


<210>  725
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to 40K PEG via thioether

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  725

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  726
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-lysine

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Sarcosine (N-methyl glycine)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  AMIDATION

<400>  726

Lys Gly His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  727
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-lysine

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  N-hexyl-glycine

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via maleimide

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  AMIDATION

<400>  727

Lys Gly His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  728
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-lysine

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  N-methyl phenylalanine

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  AMIDATION

<400>  728

Lys Phe His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  729
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40 kDa PEG via maleimide

<400>  729

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  730
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is DMIA

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via maleimide

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  730

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  731
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  731

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Thr Asn 
            20                  25                  30  


<210>  732
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Phe, hydroxyl-Phe, Gly, hydroxyl-Gly, Ala, Cys, Ser, Lys, 
       Glu, dehydro-Val, Pro, d-Pro, AIB, 1-aminocyclohexanecarboxylic 
       acid, 1-aminocyclopropanecarboxylic acid, N-Me-AIB, 
       alpha-alpha-diethyl-Gly, hydroxyl-AIB, or d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Pro, d-Pro, N-methyl-Gly, N-hexyl-Gly, 
       Azetidine-2-carboxylic acid, N-methyl-Ala, or N-methyl-Phe

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is His, d-His, Ala, or N-methyl-His

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  C-terminal amidation

<400>  732

Xaa Xaa Xaa Ser Arg Gly Thr Phe 
1               5               


<210>  733
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Sar

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Covalently bound to PEG via 40kDa maleimide

<400>  733

Lys Xaa His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  734
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Sar

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Cys residue linked to 40kDa PEG via maleimide

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  734

Lys Xaa His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr Asn 
            20                  25                  30          


<210>  735
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Sar

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is DMIA

<220>
<221>  MISC_FEATURE
<222>  (18)..(22)
<223>  Lactam ring between side chains of amino acids

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Covalently bound to 40kDa PEG via maleimide

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  735

Lys Xaa Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  736
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  N-hexyl-Gly

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  Covalently bound to 40K PEG via thioether

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  AMIDATION

<400>  736

Lys Gly His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  737
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  N-hexyl-Gly

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Cys residue linked to 40kDa PEG via maleimide

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  737

Lys Gly His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr Asn 
            20                  25                  30          


<210>  738
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  N-hexyl-Gly

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is DMIA

<220>
<221>  MISC_FEATURE
<222>  (18)..(22)
<223>  Lactam ring between side chains of amino acids

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Covalently bound to 40kDa PEG via maleimide

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  738

Lys Gly Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  739
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  N-methyl-Phe

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Covalently bound to 40kDa PEG via maleimide

<400>  739

Lys Phe His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  740
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  N-methyl-Phe

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Cys residue linked to 40kDa PEG via maleimide

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  740

Lys Phe His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr Asn 
            20                  25                  30          


<210>  741
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  d-Lys

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  N-methyl-Phe

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is DMIA

<220>
<221>  MISC_FEATURE
<222>  (18)..(22)
<223>  Lactam ring between side chains of amino acids

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Covalently bound to 40kDa PEG via maleimide

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  741

Lys Phe Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  742
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  742

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  743
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  743

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  744
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  744

His Xaa Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  745
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Dmia

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  745

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  746
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam ring between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  746

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Leu Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  747
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  747

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Lys Arg Ala Xaa Glu Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  748
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  748

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  749
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  749

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  750
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  750

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  751
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  751

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  752
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  752

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  753
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  753

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  754
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  754

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  755
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  755

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Leu Asp Thr 
            20                  25                  


<210>  756
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  756

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  757
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  757

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  758
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  758

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  759
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  759

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  760
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  760

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  761
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between side chains of amino acids at positions 16 
       and 20

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  761

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  762
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  762

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  763
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  763

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  764
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  764

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  765
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  765

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  766
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  766

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  767
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  767

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Glu 
            20                  25                  


<210>  768
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  768

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Glu Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Glu 
            20                  25                  


<210>  769
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  769

Xaa Xaa His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  30      


<210>  770
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  770

Xaa Xaa His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Xaa Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  30      


<210>  771
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  771

Xaa Xaa His Xaa Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu 
1               5                   10                  15      


Glu Glu Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40          


<210>  772
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(22)
<223>  Lactam ring between side chains of amino acids at positions 18 
       and 22

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  772

Xaa Xaa His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Leu Tyr Leu 
1               5                   10                  15      


Asp Glu Arg Ala Ala Lys Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  30      


<210>  773
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  773

Xaa Xaa His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Xaa Lys Arg Ala Xaa Glu Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  30      


<210>  774
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  774

Xaa Xaa His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Xaa Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  30      


<210>  775
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Cys, d-Lys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  775

Xaa Xaa His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Xaa Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  30      


<210>  776
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  776

Xaa Xaa His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Xaa Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  30      


<210>  777
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  777

Xaa Xaa His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Xaa Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  30      


<210>  778
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  778

Xaa Xaa His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  30      


<210>  779
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  779

Xaa Xaa His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Glu Xaa Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  30      


<210>  780
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  780

Xaa Xaa His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  30      


<210>  781
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  781

Xaa Xaa His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Leu Asp Thr 
            20                  25                  30      


<210>  782
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  782

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40          


<210>  783
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  783

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser 
        35                  40      


<210>  784
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  784

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser 
        35                  40      


<210>  785
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  785

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40          


<210>  786
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  786

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40          


<210>  787
<211>  42
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (18)..(22)
<223>  Lactam bridge between side chains of amino acids at positions 18 
       and 22

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  787

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Glu Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40          


<210>  788
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  788

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40          


<210>  789
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  789

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40          


<210>  790
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  Acylated with fatty acyl group

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  790

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40          


<210>  791
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Acylated with fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  791

Xaa Xaa Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40          


<210>  792
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (22)..(22)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (42)..(42)
<223>  C-terminal amidation

<400>  792

Xaa Xaa Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu 
1               5                   10                  15      


Asp Lys Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly 
            20                  25                  30          


Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40          


<210>  793
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  793

Xaa Xaa His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Xaa Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Glu 
            20                  25                  30      


<210>  794
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is AIB, d-Lys, d-Cys, d-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Gly(N-Hexyl), Gly(N-Methyl), Phe(N-Methyl)

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  794

Xaa Xaa His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu 
1               5                   10                  15      


Asp Xaa Glu Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Glu 
            20                  25                  30      


<210>  795

<400>  795
000

<210>  796

<400>  796
000

<210>  797

<400>  797
000

<210>  798

<400>  798
000

<210>  799

<400>  799
000

<210>  800

<400>  800
000

<210>  801
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  801

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  802
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Ser, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  802

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  803
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Xaa is Arg, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  803

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Xaa Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  804
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Xaa is Asp, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  804

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Gln Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  805
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Xaa is Gln, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  805

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Xaa Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  806
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Xaa is Asp, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Xaa is Gln, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  806

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Xaa Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  807
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Xaa is Lys, Arg, His, Asp, Glu, cysteic acid or homocysteic acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Xaa is Thr, Lys, Arg, His, Asp, Glu, cysteic acid or homocysteic 
       acid

<400>  807

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  808
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Xaa is Asp or Glu

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Xaa is Thr, Asp or Glu

<400>  808

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  809
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Xaa is Asp or Glu

<400>  809

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Xaa 
            20                  25                  


<210>  810
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  810

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  811
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  811

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  812
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Xaa is Lys, Arg or His

<400>  812

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Xaa 
            20                  25                  


<210>  813
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  813

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Glu Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  814
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Pegylation

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  814

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Cys 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  815
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Pegylation

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  815

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Cys Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  816
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Pegylation

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  816

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Cys Phe Val Gln Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  817
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylation

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  817

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  818
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Pegylation

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  818

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Arg Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Lys Phe Val Gln Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  819
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylation

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<400>  819

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Arg Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Lys Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  820
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing carboxy terminal 10 amino acids of 
       Exendin-4

<400>  820

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  821
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy terminal 8 amino acids 
       of oxyntomodulin

<400>  821

Lys Arg Asn Arg Asn Asn Ile Ala 
1               5               


<210>  822
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the amino 4 amino acids of 
       oxyntomodulin carboxy terminus of SEQ ID NO: 21

<400>  822

Lys Arg Asn Arg 
1               


<210>  823
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy terminal 10 amino acids
       of Exendin-4

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  AMIDATION

<400>  823

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  824
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  824

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  825
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  825

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  826
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  826

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr Lys Arg Asn 
            20                  25                  30          


Arg 
    


<210>  827
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  827

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Cys Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  828
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  828

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  829
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  2-butyrolactone bound through Cys thiol group

<400>  829

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  830
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Carboxymethyl group bound through Cys thiol group

<400>  830

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  831
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  831

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  832
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analog


<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Xaa is Asp, Glu, Lys, Arg or His

<400>  832

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr Xaa 
            20                  25                  30  


<210>  833
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Xaa is Asn, Lys, Arg, His, Asp or Glu

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Xaa is Thr, Lys, Arg, His, Asp or Glu

<400>  833

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  834
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue


<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Xaa is Asn or an acidic amino acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Xaa is Thr or an acidic amino acid

<400>  834

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  835
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  835

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Glu Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  836
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  836

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Glu Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  837
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  837

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Glu Thr Lys Arg Asn 
            20                  25                  30          


Arg 
    


<210>  838
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glucagon analogue

<400>  838

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Glu Thr 
            20                  25                  


<210>  839
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is any amino acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Met comprises Z

<400>  839

Xaa Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met 
            20                  25          


<210>  840
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is alpha, alpha-dimethyl imidiazole acetic acid (DMIA)

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylation

<400>  840

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  841
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is alpha, alpha-dimethyl imidiazole acetic acid (DMIA)

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Glutamine to alanine mutation

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Pegylation

<400>  841

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Ala Trp Leu Met Asn Cys 
            20                  25                  


<210>  842
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is alpha, alpha-dimethyl imidiazole acetic acid (DMIA)

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylation

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle or Leu

<400>  842

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Cys Trp Leu Xaa Asn Thr 
            20                  25                  


<210>  843
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is alpha, alpha-dimethyl imidiazole acetic acid (DMIA)

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Glutamine to alanine mutation

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Nle or Leu

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Pegylation

<400>  843

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Ala Trp Leu Xaa Asn Cys 
            20                  25                  


<210>  844
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with  Ala 20, Ala 24, Nle 27, and Asp 28

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  844

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  845
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Ala 20, Ala 24, Nle27 , Asp 28, and Glu 29

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  845

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  846
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Ala 20, Ala 24, Nle 27, Asp 28, and Glu 30

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  846

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Xaa Asp Thr Glu 
            20                  25                  30  


<210>  847
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Ala 20, Ala 24, Nle 27, Glu 28, and Glu 29

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  847

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Xaa Glu Glu 
            20                  25                  


<210>  848
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Ala 20, Ala 24, Nle 27, Glu 28, and Glu 30

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  848

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Xaa Glu Thr Glu 
            20                  25                  30  


<210>  849
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  SEQ ID NO: 1 with Ala 20, Ala 24, Nle 27, Glu 29, and Glu 30

<400>  849

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Xaa Asn Glu Glu 
            20                  25                  30  


<210>  850
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Ala 20, Glu 21, Ala 24, Nle 27, and Asp 28

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  850

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Thr 
            20                  25                  


<210>  851
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Ala 20, Glu 21, Ala 24, Nle 27, Asp 28, and Glu
       29

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  851

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  852
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Ala 20, Glu 21, Ala 24, Nle 27, Asp 28, and Glu
       30

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  852

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  853
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO :1 with Ala 20, Glu 21, Ala 24, Nle 27, Glu 28, and Glu
       29

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  853

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Glu Glu 
            20                  25                  


<210>  854
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Ala 20, Glu 21, Ala 24, Nle 27, Glu 28, and Glu
       30

<400>  854

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  855
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Ala 20, Glu 21, Ala 24, Nle 27, Glu 29, and Glu
       30

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  855

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asn Glu Glu 
            20                  25                  30  


<210>  856
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  SEQ ID NO: 1 with Thr 16, Ala 20, Glu 21, Ala 24, Nle 27, Asp 28,
       and Glu29

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  856

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  857
<211>  31
<212>  PRT
<213>  Homo sapiens

<400>  857

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg Gly 
            20                  25                  30      


<210>  858
<211>  30
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  AMIDATION

<400>  858

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  859
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Glutamine analog

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  859

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  860
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Glutamine analog

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutryic acid

<400>  860

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  861
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  861

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  862
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetamidomethyl-cysteine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  862

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  863
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synethic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  863

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  864
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Carbamoyldiaminopropanoic acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  864

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  865
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Methylglutamine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  865

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  866
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Methionine sulfoxide

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  866

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  867
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetylornithine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  867

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  868
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutryic acid

<400>  868

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  869
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutryic acid

<400>  869

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  870
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Methylglutamine

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  870

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  871
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  871

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Glu 
            20                  25                  


<210>  872
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  AMIDATION

<400>  872

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  873
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutryric acid

<400>  873

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ser Asp Phe Val Ser Trp Leu Leu Asp Glu 
            20                  25                  


<210>  874
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aminoisobutryic acid

<400>  874

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Thr Asp Phe Val Thr Trp Leu Leu Asp Glu 
            20                  25                  


<210>  875
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  875

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Glu 
            20                  25                  


<210>  876
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  876

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Glu 
            20                  25                  


<210>  877
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  877

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  878
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  878

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  879
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  AMIDATION

<400>  879

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  880
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  880

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  881
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  AMIDATION

<400>  881

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  882
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  882

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  883
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  883

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  884
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aminoisobutryic Acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  AMIDATION

<400>  884

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  885
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Ser or alpha, alpha-disubstituted amino acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Gln or alpha, alpha-disubstituted amino acid

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Xaa is Asp or alpha, alpha-disubstituted amino acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Xaa is Gln or alpha, alpha-disubstituted amino acid

<400>  885

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Xaa Phe Val Xaa Trp Leu Met Asn Thr 
            20                  25                  


<210>  886
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  886

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  887
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Xaa is Aib

<400>  887

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Xaa Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  888
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<400>  888

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  889
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Xaa is Aib

<400>  889

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  890
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Xaa is Aib

<400>  890

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Xaa Trp Leu Met Asn Thr 
            20                  25                  


<210>  891
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<400>  891

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  892
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Xaa is Aib

<400>  892

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Xaa Trp Leu Met Asn Thr 
            20                  25                  


<210>  893
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Xaa is Aib

<400>  893

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Xaa Trp Leu Met Asn Thr 
            20                  25                  


<210>  894
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Xaa is Aib

<400>  894

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Xaa Trp Leu Met Asn Thr 
            20                  25                  


<210>  895
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  895

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  896
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  896

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  897
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  897

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  898
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  898

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  899
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  899

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  900
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via beta-Ala-beta-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  900

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  901
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via 6-aminohexanoic acid 
       spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  901

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  902
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via Leu-Leu spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  902

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  903
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via Pro-Pro spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  903

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  904
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  904

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  905
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  905

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  906
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  906

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  907
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  907

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  908
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  908

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  909
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  909

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  910
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Cys-PEG

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  910

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  911
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  911

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  912
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  912

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  913
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C14 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  913

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  914
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  914

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  915
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covelently bound to C16 fatty acyl group via Ala-Ala spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  915

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  916
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  AMIDATION

<400>  916

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  917
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  917

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  918
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Acylated with a C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  AMIDATION

<400>  918

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  919
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  AMIDATION

<400>  919

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  920

<400>  920
000

<210>  921

<400>  921
000

<210>  922

<400>  922
000

<210>  923

<400>  923
000

<210>  924

<400>  924
000

<210>  925

<400>  925
000

<210>  926

<400>  926
000

<210>  927

<400>  927
000

<210>  928

<400>  928
000

<210>  929

<400>  929
000

<210>  930

<400>  930
000

<210>  931

<400>  931
000

<210>  932

<400>  932
000

<210>  933

<400>  933
000

<210>  934

<400>  934
000

<210>  935

<400>  935
000

<210>  936

<400>  936
000

<210>  937

<400>  937
000

<210>  938

<400>  938
000

<210>  939

<400>  939
000

<210>  940

<400>  940
000

<210>  941

<400>  941
000

<210>  942

<400>  942
000

<210>  943

<400>  943
000

<210>  944

<400>  944
000

<210>  945

<400>  945
000

<210>  946

<400>  946
000

<210>  947

<400>  947
000

<210>  948

<400>  948
000

<210>  949

<400>  949
000

<210>  950

<400>  950
000

<210>  951

<400>  951
000

<210>  952

<400>  952
000

<210>  953

<400>  953
000

<210>  954

<400>  954
000

<210>  955

<400>  955
000

<210>  956

<400>  956
000

<210>  957

<400>  957
000

<210>  958

<400>  958
000

<210>  959

<400>  959
000

<210>  960

<400>  960
000

<210>  961

<400>  961
000

<210>  962

<400>  962
000

<210>  963

<400>  963
000

<210>  964

<400>  964
000

<210>  965

<400>  965
000

<210>  966

<400>  966
000

<210>  967

<400>  967
000

<210>  968

<400>  968
000

<210>  969

<400>  969
000

<210>  970

<400>  970
000

<210>  971

<400>  971
000

<210>  972

<400>  972
000

<210>  973

<400>  973
000

<210>  974

<400>  974
000

<210>  975

<400>  975
000

<210>  976

<400>  976
000

<210>  977

<400>  977
000

<210>  978

<400>  978
000

<210>  979

<400>  979
000

<210>  980

<400>  980
000

<210>  981

<400>  981
000

<210>  982

<400>  982
000

<210>  983

<400>  983
000

<210>  984

<400>  984
000

<210>  985

<400>  985
000

<210>  986

<400>  986
000

<210>  987

<400>  987
000

<210>  988

<400>  988
000

<210>  989

<400>  989
000

<210>  990

<400>  990
000

<210>  991

<400>  991
000

<210>  992

<400>  992
000

<210>  993

<400>  993
000

<210>  994

<400>  994
000

<210>  995

<400>  995
000

<210>  996

<400>  996
000

<210>  997

<400>  997
000

<210>  998

<400>  998
000

<210>  999

<400>  999
000

<210>  1000

<400>  1000
000

<210>  1001
<211>  29
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Wild type glucagon

<400>  1001

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1002
<211>  31
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(31)
<223>  GLP-1(7-37)

<400>  1002

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg Gly 
            20                  25                  30      


<210>  1003
<211>  30
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(30)
<223>  GLP-1(7-36) amidated

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1003

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  1004
<211>  42
<212>  PRT
<213>  Homo sapiens


<220>
<221>  mat_peptide
<222>  (1)..(42)
<223>  gastric inhibitory polypeptide

<400>  1004

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Asp Trp Lys His Asn Ile Thr Gln 
        35                  40          


<210>  1005
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 61

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20.

<400>  1005

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  1006
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 62

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20.

<400>  1006

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  1007
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 63

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam bridge between residues 12 and 16.

<400>  1007

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  1008
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 66

<400>  1008

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Ala Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1009
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 68

<400>  1009

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Ile His Gln Glu Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  1010
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 69

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1010

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Ile His Gln Glu Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  1011
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 84

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1011

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Cys Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1012
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 85

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (20kDa) covalently attached to Cysteine

<400>  1012

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Cys Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1013
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 92

<400>  1013

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Lys His Gln Lys Glu Phe Ile Ala Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1014
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 93

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Lactam bridge between residues 17 and 21

<400>  1014

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Lys His Gln Lys Glu Phe Ile Ala Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1015
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 95

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1015

His Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1016
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 96

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1016

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1017
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 97

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1017

His Ala Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Met Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1018
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 98

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1018

Tyr Ala Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Met Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1019
<211>  42
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 99

<400>  1019

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  1020
<211>  42
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 100

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<400>  1020

Tyr Xaa Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  1021
<211>  42
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 101

<400>  1021

Tyr Ala Pro Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  1022
<211>  42
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 102

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<400>  1022

Tyr Xaa Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Cys Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  1023
<211>  42
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 104

<400>  1023

Tyr Ala Pro Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Cys Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  1024
<211>  42
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 105

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) attached to Cysteine

<400>  1024

Tyr Ala Pro Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Cys Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  1025
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 106

<400>  1025

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1026
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 107

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1026

His Ser Gln Gly Thr Phe Ile Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  1027
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 108

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1027

His Ser Gln Gly Thr Phe Ile Ser Asp Tyr Ser Lys Ala Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  1028
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 109

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1028

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1029
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 110

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1029

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1030
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 111

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1030

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1031
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 113

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is 3-phenyllactic acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge between residues 11 and 15

<400>  1031

Xaa Ile Ser Asp Tyr Ser Ile Ala Met Asp Glu Ile His Gln Lys Asp 
1               5                   10                  15      


Phe Val Asn Trp Leu Leu Ala Gln 
            20                  


<210>  1032
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 114

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is 3-phenyllactic acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge between residues 11 and 15

<400>  1032

Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Ile His Gln Lys Asp 
1               5                   10                  15      


Phe Val Asn Trp Leu Leu Ala Gln 
            20                  


<210>  1033
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 115

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1033

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1034
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 116

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1034

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1035
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 118

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1035

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1036
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 120

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1036

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1037
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 124

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1037

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Met Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1038
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 125

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1038

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Met Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  1039
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 127

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1039

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1040
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 128

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1040

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1041
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 129

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1041

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1042
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 139

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1042

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1043
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 140

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1043

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1044
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 141

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residuess 16 and 20

<400>  1044

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Met Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1045
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 142

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1045

Tyr Ala Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Met Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1046
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 143

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1046

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1047
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 144

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1047

Tyr Ala Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Met Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1048
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 145

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1048

Tyr Ala Gln Gly Thr Phe Ile Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1049
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 146

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1049

Tyr Ala Gln Gly Thr Phe Ile Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1050
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 147

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1050

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1051
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 148

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1051

Tyr Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1052
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 149

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1052

Tyr Ala Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1053
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 150

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1053

Tyr Ser Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1054
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 151

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1054

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1055
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 152

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1055

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1056
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 154

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is hippuric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1056

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1057
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 155

<220>
<221>  MISC_FEATURE
<222>  (12)..(16)
<223>  Lactam bridge between residues 12 and 16

<400>  1057

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1058
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 156

<220>
<221>  MISC_FEATURE
<222>  (20)..(24)
<223>  Lactam bridge between residues 20 and 24

<400>  1058

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Glu Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1059
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 157

<220>
<221>  MISC_FEATURE
<222>  (24)..(28)
<223>  Lactam bridge between residues 24 and 28

<400>  1059

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Glu Trp Leu Leu Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1060
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 158

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1060

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1061
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 162

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1061

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Tyr Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Val Lys Glu Phe Val Asn Trp Leu Ile Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1062
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 163

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1062

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1063
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 164

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1063

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1064
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 165

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1064

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1065
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 166

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is d-alanine

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1065

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1066
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 167

<220>
<221>  MISC_FEATURE
<222>  (17)..(20)
<223>  Lactam bridge between residues 17 and 20

<400>  1066

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1067
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 168

<220>
<221>  MISC_FEATURE
<222>  (18)..(21)
<223>  Lactam bridge between residues 18 and 21

<400>  1067

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Lys Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1068
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 169

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1068

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Cys Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1069
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 170

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1069

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1070
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 172

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1070

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Cys Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1071
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 174

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1071

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1072
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 175

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1072

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1073
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 176

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1073

Tyr Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1074
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 177

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1074

Tyr Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Cys Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1075
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 178

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1075

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1076
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 179

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1076

Tyr Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Cys Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1077
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 182

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1077

Tyr Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1078
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 186

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1078

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Cys Trp Leu Met Asn Gly 
            20                  25                  


<210>  1079
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 191

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<400>  1079

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1080
<211>  34
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 192

<400>  1080

Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu Gln Ala Ala Lys Glu 
1               5                   10                  15      


Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1081
<211>  38
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 194

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Aib

<400>  1081

Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu Glu 
1               5                   10                  15      


Ala Val Arg Leu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser 
            20                  25                  30          


Gly Ala Pro Pro Pro Ser 
        35              


<210>  1082
<211>  26
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 197

<220>
<221>  MISC_FEATURE
<222>  (13)..(17)
<223>  Lactam bridge between residues 13 and 17

<400>  1082

Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu Gln Ala Ala 
1               5                   10                  15      


Lys Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25      


<210>  1083
<211>  28
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 198

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge between residues 15 and 19

<400>  1083

Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu Gln 
1               5                   10                  15      


Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25              


<210>  1084
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 199

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1084

Tyr Xaa Gln Gly Thr Phe Val Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1085
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 200

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  1085

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Xaa Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1086
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 201

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<400>  1086

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1087
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 202

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1087

Tyr Xaa Gln Gly Thr Phe Val Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1088
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 203

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1088

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Xaa Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1089
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 204

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1089

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Arg Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1090
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 205

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1090

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Arg Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1091
<211>  43
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 206

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1091

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln Cys 
        35                  40              


<210>  1092
<211>  43
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 207

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1092

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln Cys 
        35                  40              


<210>  1093
<211>  43
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 208

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1093

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln Cys 
        35                  40              


<210>  1094
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Analog 209

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (9)..(12)
<223>  Lactam bridge between residues 9 and 12

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  1094

Tyr Xaa Gln Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1095
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  CEX

<400>  1095

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  1096
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is any amino acid

<400>  1096

Xaa Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10      


<210>  1097
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  1097

Lys Arg Asn Arg Asn Asn Ile Ala 
1               5               


<210>  1098
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  1098

Lys Arg Asn Arg 
1               


<210>  1099
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1099

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1100
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1100

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1101
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1101

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1102
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1102

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1103
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  18 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1103

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1104
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1104

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1105
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1105

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1106
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  18 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1106

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1107
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1107

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1108
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1108

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1109
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1109

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1110
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1110

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1111
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1111

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1112
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is Aib

<400>  1112

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1113
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1113

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Lys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1114
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1114

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Lys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1115
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  18 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1115

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Lys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1116
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1116

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Lys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1117
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1117

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1118
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1118

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1119
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  18 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1119

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1120
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1120

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1121
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Orn

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1121

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1122
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is 2,4-diaminobutyric acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1122

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1123
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalentaly attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1123

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1124
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1124

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1125
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  18 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1125

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1126
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1126

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1127
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1127

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1128
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1128

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1129
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1129

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1130
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  18 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1130

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1131
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1131

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1132
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1132

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1133
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1133

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1134
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  18 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1134

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1135
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1135

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1136
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1136

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1137
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1137

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1138
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  18 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1138

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1139
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1139

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1140
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1140

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1141
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1141

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1142
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1142

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1143
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1143

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1144
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1144

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1145
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  18 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1145

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1146
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1146

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1147
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  3-SH-propionic acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1147

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1148
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  8 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1148

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1149
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1149

Tyr Xaa Gln Gly Thr Phe Ser Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1150
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Xaa is 2-aminobutyric acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1150

Tyr Xaa Gln Gly Thr Phe Xaa Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1151
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  8 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1151

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1152
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  8 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1152

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1153
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1153

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1154
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Xaa is d-Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to d-Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1154

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1155
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Xaa is d-Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1155

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1156
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Xaa is d-Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1156

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1157
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is d-Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1157

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1158
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1158

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1159
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1159

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1160
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  1160

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  1161
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  1161

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  1162
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1162

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1163
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  1163

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  1164
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  1164

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  1165
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1165

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1166
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1166

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1167
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1167

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1168
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1168

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Gln Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1169
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (12)..(16)
<223>  Lactam bridge between residues 12 and 16

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1169

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1170
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  1170

Gly Pro Ser Ser Gly Ala Pro Pro Pro Lys 
1               5                   10  


<210>  1171
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Gly or a small, aliphatic or non-polar or slightly polar 
       amino acid

<400>  1171

Xaa Gly Pro Ser Ser Gly Ala Pro Pro Pro Lys 
1               5                   10      


<210>  1172
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic  polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is Gly or a small, aliphatic or non-polar or slightly polar 
       amino acid

<400>  1172

Xaa Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
1               5                   10          


<210>  1173
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synethic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1173

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1174
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  PEG (40kDa) covalently attached to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1174

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Gln Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1175
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1175

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1176
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1176

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1177
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1177

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1178
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  C-terminal amidation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<400>  1178

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Ser 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1179
<211>  30
<212>  PRT
<213>  Artificial Sequene

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) covalently attached to Cysteine

<400>  1179

His Xaa Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  1180
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1180

Tyr Ala Pro Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Xaa Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  1181
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalentaly linked to hydrophilic group

<400>  1181

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1182
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  misc_feature
<222>  (29)..(29)
<223>  Xaa can be any naturally occurring amino acid

<400>  1182

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Xaa Trp Leu Leu Ala Xaa 
            20                  25                  


<210>  1183
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1183

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1184
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1184

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1185
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1185

Tyr Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Xaa Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1186
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1186

Tyr Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1187
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1187

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Xaa Trp Leu Met Asn Gly 
            20                  25                  


<210>  1188
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substitute amino acid covalently linked to hydrophilic group

<400>  1188

Tyr Xaa Gln Gly Thr Phe Val Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1189
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1189

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Xaa Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1190
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1190

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Arg Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1191
<211>  43
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1191

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln Xaa 
        35                  40              


<210>  1192
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1192

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1193
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1193

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1194
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substitute amino acid covalently linked to an acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1194

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1195
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to an acyl or alkyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1195

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1196
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1196

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1197
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1197

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1198
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1198

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1199
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1199

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1200
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1200

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1201
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1201

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1202
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1202

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1203
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1203

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1204
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1204

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1205
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1205

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1206
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1206

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1207
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1207

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1208
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1208

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1209
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1209

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1210
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1210

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1211
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1211

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1212
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1212

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1213
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1213

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1214
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1214

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1215
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1215

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1216
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1216

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1217
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1217

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1218
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  1218

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Cys 
        35                  40      


<210>  1219
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1219

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1220
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  1220

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Xaa 
        35                  40      


<210>  1221
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  1221

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Xaa 
        35                  40      


<210>  1222
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1222

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1223
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1223

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1224
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synethic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1224

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1225
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Substituted amino acid covalently linked to hydrophilic group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1225

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Gln Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa 
        35                  40  


<210>  1226
<211>  30
<212>  PRT
<213>  Artificial Sequene

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Substituted amino acid covalently linked to hydrophilic group

<400>  1226

His Xaa Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  1227
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1227

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1228
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is D-Ser, D-Ala, Val, Gly, N-Methyl Ser, N-Methyl Ala, or Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Lys, Glu, Ser, Orn, Dab, Aib or any alpha, 
       alpha-disubstituted amino acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is any alpha, alpha-disubstituted amino acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Ile, Leu, or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Xaa is Ala or Gly

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Xaa is Thr, Ala, or Gly

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1228

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  1229
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1229

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Ala Gly 
            20                  25                  


<210>  1230
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is D-Ser, DAla, Val, Gly, N-Methyl Ser, N-Methyl Ala, or Aib

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Lys, Glu, Ser, Orn, Dab, Aib or any alpha, 
       alpha-disubstituted amino acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is any alpha, alpha-disubstituted amino acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Ile, Leu, or Nle

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Xaa is Ala or Gly

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Xaa is Thr, Ala, or Gly

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1230

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  1231
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Homodimer

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently bound to Lysine

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<220>
<221>  DISULFID
<222>  (41)..(41)
<223>  Disulfide bond formed with Cys residue of a second peptide having
       the same structure.

<400>  1231

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  1232
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1232

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1233
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1233

Tyr Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1234
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently bound to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1234

Tyr Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1235
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently bound to Lysine via a 
       dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1235

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1236
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently bound to Lysine via a 
       dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1236

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1237
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  16 Carbon fatty acyl group covalently bound to Lysine via 
       dipeptide spacer

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  1237

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1238
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  Homodimer

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covelently bound to Lysine

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Cys residue covalently attached to 20 kDa PEG which is in turn 
       covalently attached to a Cys residue of a second peptide having 
       the same structure

<400>  1238

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  1239
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  homodimer

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  14 Carbon fatty acyl group covalently bound to Lysine

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  PEG (5kDa) covalently bound to Cysteine

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Cys residue covalently attached to 5 kDa PEG which is in turn 
       covalently attached to a Cys residue of a second peptide having 
       the same structure

<400>  1239

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  1240
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is a Glutamine analog

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  1240

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  1241
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is a Glutamine analog

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  1241

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  1242
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  1242

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  1243
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetamidomethyl-cysteine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  1243

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  1244
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  1244

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  1245
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is carbamoyldiaminopropanoic acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  1245

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  1246
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Methylglutamine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  1246

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  1247
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Methionine sulfoxide

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  1247

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  1248
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetylornithine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa is Nle

<400>  1248

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Thr 
1               5                   10                  15      


Arg Arg Ala Ala Glu Phe Val Ala Trp Leu Xaa Asp Glu 
            20                  25                  


<210>  1249
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  1249

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  1250
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  1250

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  1251
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Methylglutamine

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  1251

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Met Asp Glu 
            20                  25                  


<210>  1252
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  1252

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1253
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  1253

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Glu 
            20                  25                  


<210>  1254
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1254

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ala Asp Phe Val Ala Trp Leu Leu Asp Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1255
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  1255

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Ser Asp Phe Val Ser Trp Leu Leu Asp Glu 
            20                  25                  


<210>  1256
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Acetyldiaminobutanoic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is Aib

<400>  1256

His Ser Xaa Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Thr Asp Phe Val Thr Trp Leu Leu Asp Glu 
            20                  25                  


<210>  1257

<400>  1257
000

<210>  1258

<400>  1258
000

<210>  1259
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge links Glu16 and Lys20

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Epsilon amine of Lys is attached to Ala-Ac-Cys(PEG), wherein the 
       Ac-Cys(PEG) is a Cys residue comprising an alpha amino group 
       capped with an acetyl group (CH3CO) and comprising a 40 kDa PEG 
       covalently attached to its side chain

<400>  1259

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1260
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge links Glu16 and Lys20

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Epsilon amine of Lys is attached to Arg-Ac-Cys(PEG), wherein the 
       Ac-Cys(PEG) is a Cys residue comprising an alpha amino group 
       capped with an acetyl group (CH3CO) and comprising a 40 kDa PEG 
       covalently attached to its side chain

<400>  1260

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1261
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge links Glu16 and Lys20

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Cys-PEG covalently linked via thioether linkage

<400>  1261

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  1262
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<400>  1262

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  1263

<400>  1263
000

<210>  1264

<400>  1264
000

<210>  1265

<400>  1265
000

<210>  1266

<400>  1266
000

<210>  1267

<400>  1267
000

<210>  1268

<400>  1268
000

<210>  1269

<400>  1269
000

<210>  1270

<400>  1270
000

<210>  1271

<400>  1271
000

<210>  1272

<400>  1272
000

<210>  1273

<400>  1273
000

<210>  1274

<400>  1274
000

<210>  1275

<400>  1275
000

<210>  1276

<400>  1276
000

<210>  1277

<400>  1277
000

<210>  1278

<400>  1278
000

<210>  1279

<400>  1279
000

<210>  1280

<400>  1280
000

<210>  1281

<400>  1281
000

<210>  1282

<400>  1282
000

<210>  1283

<400>  1283
000

<210>  1284

<400>  1284
000

<210>  1285

<400>  1285
000

<210>  1286

<400>  1286
000

<210>  1287

<400>  1287
000

<210>  1288

<400>  1288
000

<210>  1289

<400>  1289
000

<210>  1290

<400>  1290
000

<210>  1291

<400>  1291
000

<210>  1292

<400>  1292
000

<210>  1293

<400>  1293
000

<210>  1294

<400>  1294
000

<210>  1295

<400>  1295
000

<210>  1296

<400>  1296
000

<210>  1297

<400>  1297
000

<210>  1298

<400>  1298
000

<210>  1299

<400>  1299
000

<210>  1300

<400>  1300
000

<210>  1301
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  1301

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1302
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<400>  1302

Ser Gln Gly Thr Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg 
1               5                   10                  15      


Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25              


<210>  1303
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<400>  1303

Gln Gly Thr Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg 
1               5                   10                  15      


Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25          


<210>  1304
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<400>  1304

Gly Thr Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala 
1               5                   10                  15      


Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25      


<210>  1305
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<400>  1305

Thr Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln 
1               5                   10                  15      


Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25  


<210>  1306
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is glutamic acid, cysteic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa at position 22 is Met, Leu or Nle

<400>  1306

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1307
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1307

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1308
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is  Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1308

Phe Thr Ser Asp Tyr Ser Arg Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1309
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1309

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Xaa Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1310
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1310

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Ser Arg Arg Ala Gln Xaa 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1311
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypetide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1311

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Asn Thr 
            20                  


<210>  1312
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1312

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Xaa Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Asn Thr 
            20                  


<210>  1313
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1313

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Cys Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1314
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1314

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Cys Trp Leu Xaa Asn Thr 
            20                  


<210>  1315
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Pegylated

<400>  1315

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Cys 
            20                  


<210>  1316
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1316

Phe Thr Ser Xaa Tyr Ser Arg Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Lys Trp Leu Xaa Asn Thr 
            20                  


<210>  1317
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1317

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Cys Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Cys Trp Leu Xaa Asn Thr 
            20                  


<210>  1318
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1318

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Glu Cys Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1319
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy terminal 10 amino acids
       of Exendin-4

<400>  1319

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  1320
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy terminal 8 amino acids 
       of oxyntomodulin

<400>  1320

Lys Arg Asn Arg Asn Asn Ile Ala 
1               5               


<210>  1321
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy 4 amino acids of 
       oxyntomodulin carboxy terminus

<400>  1321

Lys Arg Asn Arg 
1               


<210>  1322
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Lys, Cys, Orn, homocycstein or acetyl phenyalanine

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Lys, Cys, Orn, homocycstein or acetyl phenyalanine

<400>  1322

Phe Thr Ser Arg Tyr Ser Xaa Tyr Leu Asp Xaa Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Met Asn Thr 
            20                  


<210>  1323
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1323

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Ser Arg Arg Ala Gln Xaa 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1324
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1324

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Asn Thr Lys Arg Asn Arg Asn Asn Ile Ala 
            20                  25                  30          


<210>  1325
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1325

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1326
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Pegylation

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1326

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Ser Arg Arg Ala Gln Xaa 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn Arg Asn Asn Ile Ala 
            20                  25                  30          


<210>  1327
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1327

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Ser Arg Arg Ala Gln Xaa 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn Arg 
            20                  25              


<210>  1328
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1328

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Asn Thr Lys Arg Asn Arg 
            20                  25              


<210>  1329
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1329

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1330
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1330

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn Arg Asn Asn Ile Ala 
            20                  25                  30          


<210>  1331
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1331

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Cys 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn Arg 
            20                  25              


<210>  1332
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<400>  1332

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Cys Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1333
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<400>  1333

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1334
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  2-butyrolactone bound through thiol group of Cysteine

<400>  1334

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Cys Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1335
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Analogue

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Carboxymethyl group bound through thiol group of Cysteine

<400>  1335

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Cys Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1336
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1336

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Glu Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1337
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1337

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1338
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1338

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Glu Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1339
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Asp, Glu, cysteic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa id Thr, Asp, Glu, cysteic acid or homocysteic acid

<400>  1339

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1340
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Glu, cysteic acid, homoglutamic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or an acidic amino acid

<400>  1340

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1341
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Glu, cysteic acid, homoglutamic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr, glu or Asp

<400>  1341

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1342
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Glu, cysteic acid, homoglutamic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or an acidic amino acid

<400>  1342

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1343
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  20kDa PEG group attached to Xaa at position 11

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or an acidic amino acid

<400>  1343

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Cys Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1344
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  20kDa PEG group attached to Xaa at position 16

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or an acidic amino acid

<400>  1344

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Ser Arg Arg Ala Gln Cys 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1345
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or an acidic amino acid

<400>  1345

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Cys Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1346
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  Xaa is Lys, Cys, Orn, homocycstein or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (25)..(25)
<223>  Pegylated

<400>  1346

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa Xaa Gly Pro Ser Ser Gly Ala Pro 
            20                  25                  30          


Pro Pro Ser 
        35  


<210>  1347
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  Pegylated

<400>  1347

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser Xaa 
        35  


<210>  1348
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<400>  1348

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Arg Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1349
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met , Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  Pegylated

<400>  1349

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser Xaa 
        35  


<210>  1350
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<400>  1350

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1351
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<400>  1351

Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp Phe Val Gln Trp 
1               5                   10                  15      


Leu Met Asn Thr 
            20  


<210>  1352
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Homocysteic acid

<400>  1352

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1353
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy terminal 10 amino acids
       of Exendin-4

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<400>  1353

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser Xaa 
1               5                   10      


<210>  1354
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is phenyl lactic acid

<400>  1354

His Ser Gln Gly Thr Xaa 
1               5       


<210>  1355
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is phenyl lactic acid

<400>  1355

Ser Gln Gly Thr Xaa 
1               5   


<210>  1356
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is phenyl lactic acid

<400>  1356

Gln Gly Thr Xaa 
1               


<210>  1357
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is phenyl lactic acid

<400>  1357

Gly Thr Xaa 
1           


<210>  1358
<211>  2
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is phenyl lactic acid

<400>  1358

Thr Xaa 
1       


<210>  1359
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of His, D-histidine, 
       alpha, alpha-dimethyl imidiazole acetic acid (DMIA), N-methyl 
       histidine, alpha-methyl histidine, imidazole acetic acid, 
       desaminohistidine, hydroxyl-histidine, acetyl-histidine and

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is selected from a group consisting of Ser, D-serine, 
       D-alanine, Val, Gly, N-methyl serine, N-methyl alanine, and 
       aminoisobutyric acid (AIB)

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is selected from a group consisting of Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is phenyl lactic acid

<400>  1359

Xaa Xaa Xaa Gly Thr Xaa 
1               5       


<210>  1360
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of Ser, D-serine, 
       D-alanine, Val, Gly, N-methyl serine, N-methyl alanine, and 
       aminoisobutyric acid (AIB)

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is selected from a group consisting of Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is phenyl lactic acid

<400>  1360

Xaa Xaa Gly Thr Xaa 
1               5   


<210>  1361
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of Glu and Gln

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is phenyl lactic acid

<400>  1361

Xaa Gly Thr Xaa 
1               


<210>  1362
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate optionally replaced with amide

<400>  1362

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1363
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate optionally replaced with amide

<400>  1363

Ser Gln Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser Arg 
1               5                   10                  15      


Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25              


<210>  1364
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(5)
<223>  Threonine in position 4 and phenyl lactic acid in position 5 
       linked via ester bond

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is phenyl lactic acid

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Optional C-terminal alpha carboxylate replaced with amide

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate optionally replaced with amide

<400>  1364

Ser Gln Gly Thr Xaa Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser Arg 
1               5                   10                  15      


Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25              


<210>  1365
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  Threonine in position 5 and phenyl lactic acid in position 6 
       linked via ester bond

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is phenyl lactic acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal alpha carboxylate optionally replaced with amide

<400>  1365

His Ser Gln Gly Thr Xaa Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1366
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is amino isobutyric acid

<400>  1366

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1367
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<400>  1367

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1368
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of His, D-histidine, 
       alpha, alpha-dimethyl imidiazole acetic acid (DMIA), N-methyl 
       histidine, alpha-methyl histidine, imidazole acetic acid, 
       desaminohistidine, hydroxyl-histidine, acetyl-histidine and

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is selected from a group consisting of Ser, D-serine, 
       D-alanine, Val, Gly, N-methyl serine, N-methyl alanine, and 
       aminoisobutyric acid (AIB)

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is selected from a group consisting of Glu or Gln

<400>  1368

Xaa Xaa Xaa Thr Gly Phe 
1               5       


<210>  1369
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of Ser, D-serine, 
       D-alanine, Val, Gly, N-methyl serine, N-methyl alanine, and 
       aminoisobutyric acid (AIB)

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is selected from a group consisting of Glu or Gln

<400>  1369

Xaa Xaa Thr Gly Phe 
1               5   


<210>  1370
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of Glu or Gln

<400>  1370

Xaa Thr Gly Phe 
1               


<210>  1371
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate optionally replaced with an amide

<400>  1371

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1372

<400>  1372
000

<210>  1373

<400>  1373
000

<210>  1374

<400>  1374
000

<210>  1375

<400>  1375
000

<210>  1376

<400>  1376
000

<210>  1377

<400>  1377
000

<210>  1378

<400>  1378
000

<210>  1379

<400>  1379
000

<210>  1380

<400>  1380
000

<210>  1381

<400>  1381
000

<210>  1382

<400>  1382
000

<210>  1383

<400>  1383
000

<210>  1384

<400>  1384
000

<210>  1385

<400>  1385
000

<210>  1386

<400>  1386
000

<210>  1387

<400>  1387
000

<210>  1388

<400>  1388
000

<210>  1389

<400>  1389
000

<210>  1390

<400>  1390
000

<210>  1391

<400>  1391
000

<210>  1392

<400>  1392
000

<210>  1393

<400>  1393
000

<210>  1394

<400>  1394
000

<210>  1395

<400>  1395
000

<210>  1396

<400>  1396
000

<210>  1397

<400>  1397
000

<210>  1398

<400>  1398
000

<210>  1399

<400>  1399
000

<210>  1400

<400>  1400
000

<210>  1401
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  1401

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1402
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<400>  1402

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1403
<211>  31
<212>  PRT
<213>  Homo sapiens

<400>  1403

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg Gly 
            20                  25                  30      


<210>  1404
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  1404

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  1405
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<400>  1405

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1406
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<400>  1406

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1407
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ser or Glu

<400>  1407

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Glu Trp Leu Met Asn Thr 
            20                  


<210>  1408
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ser or Glu

<400>  1408

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Glu Trp Leu Met Lys Thr 
            20                  


<210>  1409
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa at position 7 is Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, homoglutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ala, Ser, Glu, Lys, homoglutamic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Gln, Glu or Lys

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Ala, Gln, Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Lys or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or an acidic amino acid

<400>  1409

Phe Thr Ser Asp Tyr Ser Xaa Tyr Leu Xaa Xaa Arg Arg Ala Xaa Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Met Xaa Xaa 
            20                  


<210>  1410
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ala, Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Gln or Lys

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Ala, Gln or Glu

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Lys or an acidic amino acid

<400>  1410

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa Arg Arg Ala Xaa Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Met Xaa Thr 
            20                  


<210>  1411
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ala, Ser, Glu, Gln, homoglutamic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Gln or Lys

<400>  1411

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa Arg Arg Ala Xaa Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1412
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Lys or Gln

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Lys, Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1412

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Asp Glu Arg Arg Ala Xaa Xaa 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Asn Thr 
            20                  


<210>  1413
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Lys or Gln

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1413

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Xaa Xaa 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1414
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Lys or Gln

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Cys, Orn, homocysteine or acetyl phenylalanine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1414

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Xaa Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Asn Thr 
            20                  


<210>  1415
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid, homoglutamic 
       acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ala, Ser, Glu, Lys Gln, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Arg, Gln, Glu or Lys

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Ala, Gln, Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Lys or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or an acidic amino acid

<400>  1415

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Xaa Xaa Arg Arg Ala Xaa Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1416
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Asp or Glu

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1416

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Thr 
            20                  


<210>  1417
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Asp or Glu

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1417

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Thr 
            20                  


<210>  1418
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ser or Glu

<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Asp or Glu

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1418

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Xaa Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Glu Trp Leu Xaa Xaa Thr 
            20                  


<210>  1419
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ser or Glu

<220>
<221>  MISC_FEATURE
<222>  (19)..(23)
<223>  Lactam bridge connecting residues 19 and 23

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr or Glu

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1419

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Xaa Xaa Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Glu Trp Leu Xaa Lys Xaa 
            20                  


<210>  1420
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ala, Ser, Glu, Lys Gln, homoglutamic acid or homocysteine

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Arg, Gln, Glu or Lys

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Ala, Gln, Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Lys, Asp, Glu, cysteic acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr, Asp, Glu, cysteic acid and homocysteic acid

<400>  1420

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Xaa Xaa Arg Arg Ala Xaa Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1421
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy terminal 10 amino acids
       of Exendin-4

<400>  1421

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  1422
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid and homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1422

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1423
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid and homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1423

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1424
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid and homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1424

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Glu Trp Leu Xaa Asn Thr 
            20                  


<210>  1425
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid and homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (19)..(24)
<223>  Lactam bridge connecting residues 19 and 24

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<400>  1425

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Glu Trp Leu Xaa Lys Thr 
            20                  


<210>  1426
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy terminal 8 amino acids 
       of oxyntomodulin

<400>  1426

Lys Arg Asn Arg Asn Asn Ile Ala 
1               5               


<210>  1427
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy 4 amino acids of 
       oxyntomodulin carboxy terminus

<400>  1427

Lys Arg Asn Arg 
1               


<210>  1428
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<400>  1428

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1429
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<400>  1429

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1430
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<400>  1430

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1431
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<400>  1431

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1432
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<400>  1432

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1433
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<400>  1433

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1434
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<400>  1434

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1435
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<400>  1435

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1436
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<400>  1436

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1437
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<400>  1437

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ala Arg Tyr Leu Asp Ala 
1               5                   10                  15      


Arg Arg Ala Arg Glu Phe Ile Lys Trp Leu Val Arg Gly Arg Gly 
            20                  25                  30      


<210>  1438
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1438

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1439
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1439

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Asn Thr 
            20                  


<210>  1440
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<400>  1440

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Cys Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1441
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Analogue

<400>  1441

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1442
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  2-butyrolactone bound through thiol group of Cysteine

<400>  1442

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Cys Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1443
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon Analogue

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Carboxymethyl group bound through thiol group of Cysteine

<400>  1443

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Cys Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1444
<211>  39
<212>  PRT
<213>  Homo sapiens

<400>  1444

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Arg Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Arg Asn Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  1445
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Lys, Asp, Glu, cysteic acid and homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr, Asp, Glu, cysteic acid and homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  Xaa is Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (25)..(25)
<223>  Pegylated

<400>  1445

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa Xaa Gly Pro Ser Ser Gly Ala Pro 
            20                  25                  30          


Pro Pro Ser 
        35  


<210>  1446
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Lys, Asp, Glu, cysteic acid and homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr, Asp, Glu, cysteic acid and homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Cys, Orn, homocysteine or acetyl phenyalanine

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  Pegylated

<400>  1446

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser Xaa 
        35  


<210>  1447
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is glutamic acid, homoglutamic acid, cysteic acid or 
       homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Asp or Glu

<400>  1447

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Thr 
            20                  


<210>  1448
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is glutamic acid, homoglutamic acid,  cysteic acid or 
       homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Asp or Glu

<400>  1448

Phe Thr Ser Xaa Tyr Ser Lys Tyr Leu Xaa Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Xaa Xaa Thr 
            20                  


<210>  1449
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<400>  1449

Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp Phe 
1               5                   10                  15      


Val Gln Trp Leu Met Asp Thr 
            20              


<210>  1450
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Peptide fragment representing the carboxy terminal 10 amino acids
       of Exendin-4 plus one additional amino acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is selected form the group consisting of Cys, Orn, Lys, 
       homocysteine and acetyl phenyalanine

<400>  1450

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser Xaa 
1               5                   10      


<210>  1451
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  Glucagon analogue

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is aspartic acid, glutamic acid, cysteic acid, homoglutamic 
       acid or homocysteic acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Asp, Glu, cysteic acid, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Ala, Ser, Glu, Lys Gln, homoglutamic acid or homocysteic 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Arg, Gln, Glu or Lys

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Ala, Gln, Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  Xaa is Met, Leu or Nle

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa is Asn, Lys or an acidic amino acid

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is Thr, Gly or an acidic amino acid

<400>  1451

Phe Thr Ser Xaa Tyr Ser Xaa Tyr Leu Xaa Xaa Arg Arg Ala Xaa Asp 
1               5                   10                  15      


Phe Val Xaa Trp Leu Xaa Xaa Xaa 
            20                  


<210>  1452
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is phenyl lactic acid

<400>  1452

His Ser Gln Gly Thr Xaa 
1               5       


<210>  1453
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is phenyl lactic acid

<400>  1453

Ser Gln Gly Thr Xaa 
1               5   


<210>  1454
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is phenyl lactic acid

<400>  1454

Gln Gly Thr Xaa 
1               


<210>  1455
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is phenyl lactic acid

<400>  1455

Gly Thr Xaa 
1           


<210>  1456
<211>  2
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is phenyl lactic acid

<400>  1456

Thr Xaa 
1       


<210>  1457
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of His, D-histidine, 
       alpha, alpha-dimethyl imidiazole acetic acid (DMIA), N-methyl 
       histidine, alpha-methyl histidine, imidazole acetic acid, 
       desaminohistidine, hydroxyl-histidine, acetyl-histidine and

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is selected from a group consisting of Ser, D-serine, 
       D-alanine, Val, Gly, N-methyl serine, N-methyl alanine, and 
       aminoisobutyric acid (AIB)

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is selected from a group consisting of Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is phenyl lactic acid

<400>  1457

Xaa Xaa Xaa Gly Thr Xaa 
1               5       


<210>  1458
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of Ser, D-serine, 
       D-alanine, Val, Gly, N-methyl serine, N-methyl alanine, and 
       aminoisobutyric acid (AIB)

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is selected from a group consisting of Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is phenyl lactic acid

<400>  1458

Xaa Xaa Gly Thr Xaa 
1               5   


<210>  1459
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is phenyl lactic acid

<400>  1459

Xaa Gly Thr Xaa 
1               


<210>  1460
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1460

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1461
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1461

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1462
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (4)..(7)
<223>  Lactam bridge connecting residues 4 and 7

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1462

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1463
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1463

Ala Glu Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg 
1               5                   10                  15      


Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25              


<210>  1464
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(5)
<223>  Threonine in position 4 and phenyl lactic acid in position 5 are 
       linked via ester bond

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is phenyl lactic acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1464

Ala Glu Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg 
1               5                   10                  15      


Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25              


<210>  1465
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1465

Ser Gln Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg 
1               5                   10                  15      


Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25              


<210>  1466
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(5)
<223>  Threonine in position 4 and phenyl lactic acid in position 5 are 
       linked via ester bond

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is phenyl lactic acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1466

Ser Gln Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg 
1               5                   10                  15      


Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25              


<210>  1467
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Covalently linked to a cholesterol acid moiety

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 to 15

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1467

Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1468
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  Covalently linked to a cholesterol acid moiety

<220>
<221>  MOD_RES
<222>  (25)..(25)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1468

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr Lys 
            20                  25  


<210>  1469
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connectiong residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Covalently linked to a cholesterol acid moiety

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1469

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser Lys 
        35  


<210>  1470
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is amino isobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(5)
<223>  Threonine in position 4 and phenyl lactic acid in position 5 are 
       linked via ester bond

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is phenyl lactic acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connectiong residues 15 and 19

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1470

Xaa Glu Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg 
1               5                   10                  15      


Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25              


<210>  1471
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (34)..(34)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1471

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1472
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (34)..(34)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1472

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1473
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (34)..(34)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1473

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1474
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (34)..(34)
<223>  C-termincal alpha carboxylate replaced with amide

<400>  1474

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1475
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1475

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1476
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1476

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1477
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1477

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Glu Trp Leu Met Asp Thr 
            20                  


<210>  1478
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (19)..(23)
<223>  Lactam bridge connecting residues 19 and 23

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1478

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Glu Trp Leu Met Lys Thr 
            20                  


<210>  1479
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1479

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Gln Ala Ala Lys Asp 
1               5                   10                  15      


Phe Ile Ala Trp Leu Met Asp Thr 
            20                  


<210>  1480
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1480

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Gln Ala Ala Lys Glu 
1               5                   10                  15      


Phe Ile Ala Trp Leu Met Asp Thr 
            20                  


<210>  1481
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1481

Ala Glu Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg 
1               5                   10                  15      


Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25              


<210>  1482
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1482

Ala Glu Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Gln 
1               5                   10                  15      


Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25              


<210>  1483
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge connection residues 16 and 20

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1483

His Ala Glu Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1484
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge connecting bridges 16 and 20

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1484

His Ala Glu Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asp Thr 
            20                  25                  


<210>  1485
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (13)..(17)
<223>  Lactam bridge connecting residues 13 and 17

<220>
<221>  MOD_RES
<222>  (26)..(26)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1485

Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala 
1               5                   10                  15      


Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25      


<210>  1486
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  Threonine in position 5 and phenyl lactic acid in position 6 
       linked via ester bond

<220>
<221>  MISC_FEATURE
<222>  (15)..(19)
<223>  Lactam bridge connecting residues 15 and 19

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1486

Ser Gln Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg 
1               5                   10                  15      


Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25              


<210>  1487
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  Threonine at position 5 and phenyl lactic acid at position 6 
       linked via ester bond

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is phenyl lactic acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge connecting residues 16 and 20

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1487

His Ala Glu Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1488
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1488

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Cys Trp Leu Met Asp Thr 
            20                  


<210>  1489
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (7)..(11)
<223>  Lactam bridge connecting residues 7 and 11

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1489

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser Cys 
        35  


<210>  1490
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1490

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Cys Trp Leu Met Asp Thr 
            20                  


<210>  1491
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1491

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser Cys 
        35  


<210>  1492
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Covalently attached to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connection residues 11 and 15

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1492

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1493
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Linked to a C16 fatty acid via Glu residue

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Linked to a C16 fatty acid via Glu residue

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1493

Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1494
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Linked to C16 fatty acid via Glu residue

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1494

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1495
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Linked to a C16 fatty acid via Glu residue

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1495

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Lys Trp Leu Met Asp Thr 
            20                  


<210>  1496
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Linked to a C16 fatty acid via Glu residue

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1496

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Lys 
            20                  


<210>  1497
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is amino isobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1497

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1498
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is alpha isobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1498

Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa Arg Arg Ala Xaa Asp 
1               5                   10                  15      


Phe Val Cys Trp Leu Met Asn Thr 
            20                  


<210>  1499
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1499

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1500
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1500

Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Cys Trp Leu Met Asn Thr 
            20                  


<210>  1501
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(7)
<223>  Lactam bridge connecting residues 4 and 7

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  Xaa is alpha isobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal carboxylate replaced with amide

<400>  1501

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Xaa Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1502
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(7)
<223>  Lactam bridge connecting residues 4 and 7

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  Xaa is alpha isobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal carboxylate replaced with amide

<400>  1502

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Xaa Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr 
            20                  


<210>  1503
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1503

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Glu 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1504
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1504

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Gln Ala Ala Lys Glu 
1               5                   10                  15      


Phe Ile Ala Trp Leu Met Asn Thr 
            20                  


<210>  1505
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (34)..(34)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1505

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asn Thr Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  1506
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Linked to a C16 fatty acid via Glu residue

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Linked to a C16 fatty acid via Glu residue

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal carboxylate replaced with amide

<400>  1506

Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1507
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is selected from a group consisting of His, D-histidine, 
       alpha, alpha-dimethyl imidiazole acetic acid (DMIA), N-methyl 
       histidine, alpha-methyl histidine, imidazole acetic acid, 
       desaminohistidine, hydroxyl-histidine, acetyl-histidine and

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is selected from a group consisting of Ser, D-serine, 
       D-alanine, valine, glycine, N-methyl serine, and aminoisobutyric 
       acid (AIB)

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is selected from a group consisting of Glu or Gln

<400>  1507

Xaa Xaa Xaa Thr Gly Phe 
1               5       


<210>  1508
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of Ser, D-serine, 
       D-alanine, valine, glycine, N-methyl serine, and aminoisobutyric 
       acid (AIB)

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is selected from a group consisting of Glu or Gln

<400>  1508

Xaa Xaa Thr Gly Phe 
1               5   


<210>  1509
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from a group consisting of Glu or Gln

<400>  1509

Xaa Thr Gly Phe 
1               


<210>  1510
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1510

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser Arg Arg Ala Gln Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr 
            20                  


<210>  1511
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1511

Ser Gln Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser Arg 
1               5                   10                  15      


Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25              


<210>  1512
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(5)
<223>  Threonine at position 4 and phenyl lactic acid at position 5 
       linked via ester bond

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is phenyl lactic acid

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1512

Ser Gln Gly Thr Xaa Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser Arg 
1               5                   10                  15      


Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25              


<210>  1513
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  Threorine at position 5 and phenyl lactic acid at position 6 
       linked via ester bond

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is phenyl lactic acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1513

His Ser Gln Gly Thr Xaa Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1514
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1514

Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Cys Trp Leu Met Asn Thr 
            20                  


<210>  1515
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Pegylated via spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1515

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Lys Trp Leu Met Asp Thr 
            20                  


<210>  1516
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  Pegylated via rigid spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1516

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Lys Trp Leu Met Asp Thr 
            20                  


<210>  1517
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  C-terminal alpha carboxylate replaced with amide

<400>  1517

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Thr Gly Pro Gly Pro Gly Pro Gly Pro 
            20                  25                  30          


Gly Pro Cys 
        35  


<210>  1518
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  N-terminal amino group replaced with hydroxy group

<220>
<221>  MISC_FEATURE
<222>  (11)..(15)
<223>  Lactam bridge connecting residues 11 and 15

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  Pegylated

<220>
<221>  MOD_RES
<222>  (35)..(35)
<223>  C-terminal alpha carboxylate reaplaced with amide

<400>  1518

Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu Arg Arg Ala Lys Asp 
1               5                   10                  15      


Phe Val Gln Trp Leu Met Asp Gly Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser Cys 
        35  


<210>  1519

<400>  1519
000

<210>  1520

<400>  1520
000

<210>  1521

<400>  1521
000

<210>  1522

<400>  1522
000

<210>  1523

<400>  1523
000

<210>  1524

<400>  1524
000

<210>  1525

<400>  1525
000

<210>  1526

<400>  1526
000

<210>  1527

<400>  1527
000

<210>  1528

<400>  1528
000

<210>  1529

<400>  1529
000

<210>  1530

<400>  1530
000

<210>  1531

<400>  1531
000

<210>  1532

<400>  1532
000

<210>  1533

<400>  1533
000

<210>  1534

<400>  1534
000

<210>  1535

<400>  1535
000

<210>  1536

<400>  1536
000

<210>  1537

<400>  1537
000

<210>  1538

<400>  1538
000

<210>  1539

<400>  1539
000

<210>  1540

<400>  1540
000

<210>  1541

<400>  1541
000

<210>  1542

<400>  1542
000

<210>  1543

<400>  1543
000

<210>  1544

<400>  1544
000

<210>  1545

<400>  1545
000

<210>  1546

<400>  1546
000

<210>  1547

<400>  1547
000

<210>  1548

<400>  1548
000

<210>  1549

<400>  1549
000

<210>  1550

<400>  1550
000

<210>  1551

<400>  1551
000

<210>  1552

<400>  1552
000

<210>  1553

<400>  1553
000

<210>  1554

<400>  1554
000

<210>  1555

<400>  1555
000

<210>  1556

<400>  1556
000

<210>  1557

<400>  1557
000

<210>  1558

<400>  1558
000

<210>  1559

<400>  1559
000

<210>  1560

<400>  1560
000

<210>  1561

<400>  1561
000

<210>  1562

<400>  1562
000

<210>  1563

<400>  1563
000

<210>  1564

<400>  1564
000

<210>  1565

<400>  1565
000

<210>  1566

<400>  1566
000

<210>  1567

<400>  1567
000

<210>  1568

<400>  1568
000

<210>  1569

<400>  1569
000

<210>  1570

<400>  1570
000

<210>  1571

<400>  1571
000

<210>  1572

<400>  1572
000

<210>  1573

<400>  1573
000

<210>  1574

<400>  1574
000

<210>  1575

<400>  1575
000

<210>  1576

<400>  1576
000

<210>  1577

<400>  1577
000

<210>  1578

<400>  1578
000

<210>  1579

<400>  1579
000

<210>  1580

<400>  1580
000

<210>  1581

<400>  1581
000

<210>  1582

<400>  1582
000

<210>  1583

<400>  1583
000

<210>  1584

<400>  1584
000

<210>  1585

<400>  1585
000

<210>  1586

<400>  1586
000

<210>  1587

<400>  1587
000

<210>  1588

<400>  1588
000

<210>  1589

<400>  1589
000

<210>  1590

<400>  1590
000

<210>  1591

<400>  1591
000

<210>  1592

<400>  1592
000

<210>  1593

<400>  1593
000

<210>  1594

<400>  1594
000

<210>  1595

<400>  1595
000

<210>  1596

<400>  1596
000

<210>  1597

<400>  1597
000

<210>  1598

<400>  1598
000

<210>  1599

<400>  1599
000

<210>  1600

<400>  1600
000

<210>  1601

<400>  1601
000

<210>  1602

<400>  1602
000

<210>  1603

<400>  1603
000

<210>  1604

<400>  1604
000

<210>  1605

<400>  1605
000

<210>  1606

<400>  1606
000

<210>  1607

<400>  1607
000

<210>  1608

<400>  1608
000

<210>  1609

<400>  1609
000

<210>  1610

<400>  1610
000

<210>  1611

<400>  1611
000

<210>  1612

<400>  1612
000

<210>  1613

<400>  1613
000

<210>  1614

<400>  1614
000

<210>  1615

<400>  1615
000

<210>  1616

<400>  1616
000

<210>  1617

<400>  1617
000

<210>  1618

<400>  1618
000

<210>  1619

<400>  1619
000

<210>  1620

<400>  1620
000

<210>  1621

<400>  1621
000

<210>  1622

<400>  1622
000

<210>  1623

<400>  1623
000

<210>  1624

<400>  1624
000

<210>  1625

<400>  1625
000

<210>  1626

<400>  1626
000

<210>  1627

<400>  1627
000

<210>  1628

<400>  1628
000

<210>  1629

<400>  1629
000

<210>  1630

<400>  1630
000

<210>  1631

<400>  1631
000

<210>  1632

<400>  1632
000

<210>  1633

<400>  1633
000

<210>  1634

<400>  1634
000

<210>  1635

<400>  1635
000

<210>  1636

<400>  1636
000

<210>  1637

<400>  1637
000

<210>  1638

<400>  1638
000

<210>  1639

<400>  1639
000

<210>  1640

<400>  1640
000

<210>  1641

<400>  1641
000

<210>  1642

<400>  1642
000

<210>  1643

<400>  1643
000

<210>  1644

<400>  1644
000

<210>  1645

<400>  1645
000

<210>  1646

<400>  1646
000

<210>  1647

<400>  1647
000

<210>  1648

<400>  1648
000

<210>  1649

<400>  1649
000

<210>  1650

<400>  1650
000

<210>  1651

<400>  1651
000

<210>  1652

<400>  1652
000

<210>  1653

<400>  1653
000

<210>  1654

<400>  1654
000

<210>  1655

<400>  1655
000

<210>  1656

<400>  1656
000

<210>  1657

<400>  1657
000

<210>  1658

<400>  1658
000

<210>  1659

<400>  1659
000

<210>  1660

<400>  1660
000

<210>  1661

<400>  1661
000

<210>  1662

<400>  1662
000

<210>  1663

<400>  1663
000

<210>  1664

<400>  1664
000

<210>  1665

<400>  1665
000

<210>  1666

<400>  1666
000

<210>  1667

<400>  1667
000

<210>  1668

<400>  1668
000

<210>  1669

<400>  1669
000

<210>  1670

<400>  1670
000

<210>  1671

<400>  1671
000

<210>  1672

<400>  1672
000

<210>  1673

<400>  1673
000

<210>  1674

<400>  1674
000

<210>  1675

<400>  1675
000

<210>  1676

<400>  1676
000

<210>  1677

<400>  1677
000

<210>  1678

<400>  1678
000

<210>  1679

<400>  1679
000

<210>  1680

<400>  1680
000

<210>  1681

<400>  1681
000

<210>  1682

<400>  1682
000

<210>  1683

<400>  1683
000

<210>  1684

<400>  1684
000

<210>  1685

<400>  1685
000

<210>  1686

<400>  1686
000

<210>  1687

<400>  1687
000

<210>  1688

<400>  1688
000

<210>  1689

<400>  1689
000

<210>  1690

<400>  1690
000

<210>  1691

<400>  1691
000

<210>  1692

<400>  1692
000

<210>  1693

<400>  1693
000

<210>  1694

<400>  1694
000

<210>  1695

<400>  1695
000

<210>  1696

<400>  1696
000

<210>  1697

<400>  1697
000

<210>  1698

<400>  1698
000

<210>  1699

<400>  1699
000

<210>  1700

<400>  1700
000

<210>  1701
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  misc_feature
<222>  (16)..(16)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1701

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Xaa Gly Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  1702
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1702

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1703
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C14 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1703

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1704
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C18 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1704

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1705
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1705

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1706
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<400>  1706

His Xaa Gln Gly Thr Phe Ile Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1707
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1707

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1708
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1708

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1709
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1709

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1710
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1710

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1711
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1711

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1712
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1712

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1713
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1713

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1714
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1714

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1715
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1715

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Gln Trp Leu Leu Asp Thr Cys 
            20                  25                  30  


<210>  1716
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1716

His Ala Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1717
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1717

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1718
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1718

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1719
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1719

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1720
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<400>  1720

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1721
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1721

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr Gly Glu 
            20                  25                  30      


<210>  1722
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<400>  1722

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr Gly Gly 
            20                  25                  30      


<210>  1723
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1723

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1724
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1724

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr Cys 
            20                  25                  30  


<210>  1725
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1725

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Glu 
            20                  25                  30  


<210>  1726
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<400>  1726

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr Cys 
            20                  25                  30  


<210>  1727
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is DMIA

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1727

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1728
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  des-amino-His

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1728

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1729
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Ac-His

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1729

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1730
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1730

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  1731
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1731

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  1732
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1732

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1733
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1733

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  1734
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1734

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1735
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1735

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1736
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1736

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  1737
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1737

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1738
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1738

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  1739
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1739

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  1740
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1740

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1741
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1741

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1742
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1742

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1743
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1743

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1744
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1744

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1745
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1745

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1746
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (15)..(20)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1746

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1747
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is DMIA

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1747

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1748
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1748

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1749
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1749

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr 
            20                  25                  


<210>  1750
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1750

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1751
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1751

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1752
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1752

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1753
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1753

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Gln Trp Leu Leu Asp Thr Cys 
            20                  25                  30  


<210>  1754
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1754

His Ala Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1755
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1755

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1756
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1756

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1757
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1757

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1758
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<400>  1758

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1759
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1759

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr Gly Glu 
            20                  25                  30      


<210>  1760
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<400>  1760

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr Gly Gly 
            20                  25                  30      


<210>  1761
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1761

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1762
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1762

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr Cys 
            20                  25                  30  


<210>  1763
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1763

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Glu 
            20                  25                  30  


<210>  1764
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<400>  1764

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr Cys 
            20                  25                  30  


<210>  1765
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa is DMIA

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1765

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1766
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  des-amino-His

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1766

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1767
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Ac-His

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1767

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Leu Asp Thr 
            20                  25                  


<210>  1768
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1768

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  1769
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1769

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1770
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1770

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  1771
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1771

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1772
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1772

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Met Asn Thr 
            20                  25                  


<210>  1773
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1773

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1774
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  PEGYLATION

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1774

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Cys Trp Leu Met Asn Thr 
            20                  25                  


<210>  1775
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Salt bridge

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1775

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1776
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-serine, D-alanine, valine, amino n-butyric acid, glycine, 
       N-methyl serine, aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (15)..(20)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(21)
<223>  Salt bridge

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  1776

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  1777

<400>  1777
000

<210>  1778

<400>  1778
000

<210>  1779

<400>  1779
000

<210>  1780

<400>  1780
000

<210>  1781

<400>  1781
000

<210>  1782

<400>  1782
000

<210>  1783

<400>  1783
000

<210>  1784

<400>  1784
000

<210>  1785

<400>  1785
000

<210>  1786

<400>  1786
000

<210>  1787

<400>  1787
000

<210>  1788

<400>  1788
000

<210>  1789

<400>  1789
000

<210>  1790

<400>  1790
000

<210>  1791

<400>  1791
000

<210>  1792

<400>  1792
000

<210>  1793

<400>  1793
000

<210>  1794

<400>  1794
000

<210>  1795

<400>  1795
000

<210>  1796

<400>  1796
000

<210>  1797

<400>  1797
000

<210>  1798

<400>  1798
000

<210>  1799

<400>  1799
000

<210>  1800

<400>  1800
000

<210>  1801
<211>  37
<212>  PRT
<213>  Homo sapiens

<400>  1801

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1802
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog

<400>  1802

His Ser Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1803
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog

<400>  1803

His Ser Asp Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1804
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1804

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Cys 
        35              


<210>  1805
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(mPEG)5kDa

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1805

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1806
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(mPEG)20kDa

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1806

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1807
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(mPEG)2 40kDa

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1807

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1808
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(9cholest-5-en-3-yl{[(2R)-3-amino-2-(amino) 
       -3-oxopropyl]thio}acetate)

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1808

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1809
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(mPEG)5kDa

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1809

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1810
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(mPEG)20kDa

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1810

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1811
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  X=aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(mPEG)2 40kDa

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1811

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1812
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(cholest-5-en-3-yl{[(2R)-3-amino-2-(amino)- 
       3-oxopropyl]thio}acetate)

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1812

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1813
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=methionine sulfoxide

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(mPEG)240kDa

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1813

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1814
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=methionine sulfoxide

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(mPEG)260kDa

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1814

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1815
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa=Cys(mPEG)240kDa

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1815

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1816
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Xaa=Cys(mPEG)240kDa

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1816

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1817
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Xaa=Cys(mPEG)240kDa

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=metionine sulfoxide

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1817

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Xaa Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1818
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  Xaa=Cys(mPEG)240kDa

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1818

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Xaa Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1819
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Lys(palmitoyl)

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1819

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1820
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Xaa=desamino-His (deltaNH2-H)

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=mrtionine sulfoxide

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(mPEG)240kDa

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1820

Xaa Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1821
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1821

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1822
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  Xaa=Cys(mPEG)240kDa

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=methionine sulfoxide

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1822

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Xaa Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1823
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Xaa=Cys(mPEG)240kDa

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=Methionine sulfoxide

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1823

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Xaa Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1824
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Lys(palmitoyl)

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1824

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1825
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=Nle

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1825

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Cys 
        35              


<210>  1826
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=O-methyl-L-homoserine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1826

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Cys 
        35              


<210>  1827
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=Nle

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(cholest-5-en-3-yl{[(2R)-3-amino-2-(amino)- 
       3-oxopropyl]thio}acetate)

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1827

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1828
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=O-methyl-L-homoserine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(cholest-5-en-3-yl{[(2R)-3-amino-2-(amino)- 
       3-oxopropyl]thio}acetate)

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1828

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1829
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1829

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1830
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1830

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Cys 
        35              


<210>  1831
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=metionine sulfoxide

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1831

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1832
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=methionine sulfoxide

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(CH2CONH2)

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1832

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1833
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=1-Amino-1-cyclohexane carboxylic acid

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1833

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1834
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Abu

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1834

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1835
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-abu

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1835

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1836
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Nva (Aminovaleric acid)

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1836

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1837
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa= beta-cyclopropyl-alanine

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1837

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1838
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=propargylglycine

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1838

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1839
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Allylglycine

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1839

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1840
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=2-Amino-2-cyclohexyl-propanoic acid

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1840

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1841
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-tertbutylglycine

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1841

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1842
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Vinylglycine

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1842

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1843
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=1-Amino-1-cyclopropane carboxylic acid

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1843

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1844
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=1-Amino-1-cyclobutane carboxylic acid

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1844

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1845
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=1-Amino-1-cyclopentane carboxylic acid

<220>
<221>  MOD_RES
<222>  (37)..(37)
<223>  C-terminal amidation

<400>  1845

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1846
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1846

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Cys 
        35              


<210>  1847
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1847

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Cys 
            20                  25                  30      


<210>  1848
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1848

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Cys 
            20                  25                  30      


<210>  1849
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1849

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Cys 
            20                  25                  30      


<210>  1850
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1850

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Cys 
            20                  25                  30      


<210>  1851
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  C-terminal amidation

<400>  1851

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1852
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1852

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1853
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  X=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1853

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1854
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1854

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1855
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1855

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1856
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=Lys(Palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1856

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1857
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=Lys(palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1857

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1858
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=Ttds

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Lys(Palmitoyl)

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  1858

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1859
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=Ttds

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Lys(Palmitoyl)

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  1859

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1860
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl{[(2R)-3-amino-2-(amino)- 
       3-oxopropyl]thio}acetate)

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  1860

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1861
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl{[(2R)-3-amino-2-(amino)- 
       3-oxopropyl]thio}acetate)

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  1861

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1862
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa= Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1862

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1863
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  Xaa=Cys(cholest-5-en-3-yl{[(2R)-3-amino-2-(amino)- 
       3-oxopropyl]thio}acetate)

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1863

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa Xaa 
        35                  


<210>  1864
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  1864

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Xaa 
            20                  25                  30          


<210>  1865
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<400>  1865

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa 
        35              


<210>  1866
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol))

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1866

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1867
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl{[(2R)-3-amino-2-(amino)- 
       3-oxopropyl]thio}acetate)

<400>  1867

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1868
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (38)..(38)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  Xaa=Lys(Palmitoyl)

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  1868

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Glu Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala Xaa Xaa 
        35                  


<210>  1869
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=Cys(cholest-5-en-3-yl{[(2R)-3-amino-2-(amino)- 
       3-oxopropyl]thio}acetate)

<400>  1869

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1870
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}acetate )

<400>  1870

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ser Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1871
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}acetate );

<400>  1871

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1872
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol)

<400>  1872

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ser Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1873
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol)

<400>  1873

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1874
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}acetate )

<400>  1874

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1875
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol)

<400>  1875

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1876
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol)

<400>  1876

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1877
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-{1-[46-(cholest-5-en-3-yloxy)-3,43,46-trioxo 
       -7,10,13,16,19,22,25,28,31,34,37,40-dodecaoxa-4,44 
       -diazahexatetracont-1-yl]-2,5-dioxopyrrolidin-3-yl }-L-cysteine 
       or Cys (mal-oxa12-cholesterol)

<400>  1877

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1878
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa== Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol)

<400>  1878

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1879
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=1-Amino-1-cyclobutane carboxylic acid

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=Cys(cholest-5-en-3-yl 
       1-{[(2R)-3-amino-2-(amino)-3-oxopropyl]thio}-2-oxo 
       -6,9,12,15-tetraoxa-3-azaoctadecan-18-oate]) or 
       Cys(Oxa4-cholesterol)

<400>  1879

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1880
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between side chains

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[42-(cholest-5-en-3-yloxy)-2,42-dioxo-6,9,12 
       ,15,18,21,24,27,30,33,36,39-dodecaoxa-3-azadotetra 
       cont-1-yl]-L-cysteine or Cys (oxa12-cholesterol)

<400>  1880

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1881
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between side chains

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[42-(cholest-5-en-3-yloxy)-2,42-dioxo-6,9,12 
       ,15,18,21,24,27,30,33,36,39-dodecaoxa-3-azadotetra 
       cont-1-yl]-L-cysteine or Cys (oxa12-cholesterol)

<400>  1881

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1882
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=1-Amino-1-cyclobutane carboxylic acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between side chains

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[42-(cholest-5-en-3-yloxy)-2,42-dioxo-6,9,12 
       ,15,18,21,24,27,30,33,36,39-dodecaoxa-3-azadotetra 
       cont-1-yl]-L-cysteine or Cys (oxa12-cholesterol)

<400>  1882

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1883
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[42-(cholest-5-en-3-yloxy)-2,42-dioxo-6,9,12 
       ,15,18,21,24,27,30,33,36,39-dodecaoxa-3-azadotetra 
       cont-1-yl]-L-cysteine or Cys (oxa12-cholesterol)

<400>  1883

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1884
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[42-(cholest-5-en-3-yloxy)-2,42-dioxo-6,9,12 
       ,15,18,21,24,27,30,33,36,39-dodecaoxa-3-azadotetra 
       cont-1-yl]-L-cysteine or Cys (oxa12-cholesterol)

<400>  1884

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1885
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=1-Amino-1-cyclobutane carboxylic acid

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[42-(cholest-5-en-3-yloxy)-2,42-dioxo-6,9,12 
       ,15,18,21,24,27,30,33,36,39-dodecaoxa-3-azadotetra 
       cont-1-yl]-L-cysteine or Cys (oxa12-cholesterol)

<400>  1885

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1886
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=Lys(gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  C-terminal amidation

<400>  1886

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1887
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[42-(cholest-5-en-3-yloxy)-2,42-dioxo-6,9,12 
       ,15,18,21,24,27,30,33,36,39-dodecaoxa-3-azadotetra 
       cont-1-yl]-L-cysteine or Cys (oxa12-cholesterol)

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  C-terminal amidation

<400>  1887

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1888
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa=Lys(gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  1888

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1889
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1889

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1890
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1890

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  1891
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1891

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  1892
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1892

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  1893
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[78-(cholest-5-en-3-yloxy)-2,78-dioxo-6,9,12 
       ,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,6 
       3,66,69,72,75-tetracosaoxa-3-azaoctaheptacont-1-yl ]-L-cysteine 
       or Cys (oxa24-cholesterol)

<400>  1893

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1894
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Xaa=Lys(DOTA)

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=methionine sulfoxide

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[42-(cholest-5-en-3-yloxy)-2,42-dioxo-6,9,12 
       ,15,18,21,24,27,30,33,36,39-dodecaoxa-3-azadotetra 
       cont-1-yl]-L-cysteine or Cys (oxa12-cholesterol)

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  C-terminal amidation

<400>  1894

His Xaa Asp Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Xaa Trp Leu Xaa Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1895
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1895

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1896
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  C-terminal amidation

<400>  1896

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1897
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=aib

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1897

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  1898
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=acb

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  1898

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  1899
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-Serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa=aib

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1899

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1900
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=aib

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=Lys(gamma glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  C-terminal amidation

<400>  1900

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1901
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=acb

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=Lys(gamma glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  C-terminal amidation

<400>  1901

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1902
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (31)..(32)
<223>  Xaa=gamma glutamic acid

<220>
<221>  MOD_RES
<222>  (33)..(33)
<223>  Xaa=S-[38-(cholest-5-en-3-yloxy)-2-oxo-6,9,12,15,1 
       8,21,24,27,30,33,36-undecaoxa-3-azaoctatriacont-1- yl]-L-cysteine
       or Cys (oxa12-O-cholesterol)

<400>  1902

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa Xaa 
            20                  25                  30          


Xaa 
    


<210>  1903
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  Xaa=D-serine or Aib;

<220>
<221>  VARIANT
<222>  (17)..(17)
<223>  Xaa=Arg or Glu

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  Xaa=Arg or Ala

<220>
<221>  VARIANT
<222>  (27)..(27)
<223>  Xaa=methionine, norleucine, or O-methyl-L-homoserine

<400>  1903

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Xaa Xaa Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys 
            20                  25                  30  


<210>  1904
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM peptide

<400>  1904

Arg Asn Arg Asn Asn Ile Ala 
1               5           


<210>  1905
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  Xaa=D-serine; Aib; Acb; 1-Amino-1-cyclohexane carboxylic acid 
       (Acx); alpha-aminobutyric acid(Abu); D- alpha-aminobutyric acid 
       (D-Abu); Aminovaleric acid Nva); beta-cyclopropyl-alanine (Cpa); 
       propargylglycine (Prg); Allylglycine (Alg);

<220>
<221>  VARIANT
<222>  (17)..(17)
<223>  Xaa=Arg or Glu

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  Xaa=Arg or Ala

<220>
<221>  VARIANT
<222>  (27)..(27)
<223>  Xaa=methionine (M), norleucine (Nle), methionine sulfoxide (m) or
       O-methyl-L-homoserine (o)

<400>  1905

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Xaa Xaa Ala Gln Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1906
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  Xaa = D-Ser,  Aib,  Acb, Acx,  Abu, D-Abu, Aminovaleric acid 
       (Nva), Cpa, Prg, Alg, 2-Cha, D-tbg, Vg, Acp, or Acpe

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  Xaa=Ser or Lys

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  Xaa=Ser or Glu

<220>
<221>  VARIANT
<222>  (17)..(17)
<223>  Xaa=Arg or Glu

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  Xaa=Arg or Ala

<220>
<221>  VARIANT
<222>  (20)..(20)
<223>  Xaa=Gln or Lys

<220>
<221>  VARIANT
<222>  (27)..(27)
<223>  Xaa=a methionine, norleucine, methionine sulfoxide, or 
       O-methyl-L-homoserine

<400>  1906

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Xaa Tyr Leu Asp Xaa 
1               5                   10                  15      


Xaa Xaa Ala Xaa Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210>  1907
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  Xaa = D-Ser,  Aib,  Acb, Acx,  Abu, D-Abu, Aminovaleric acid 
       (Nva), Cpa, Prg, Alg, 2-Cha, D-tbg, Vg, Acp, or Acpe

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  Xaa=Tyr or Lys

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  Xaa=Ser or Lys

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  Xaa=Ser or Glu

<220>
<221>  VARIANT
<222>  (17)..(17)
<223>  Xaa=Arg or Glu

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  Xaa=Arg or Ala

<220>
<221>  VARIANT
<222>  (20)..(20)
<223>  Xaa=Gln or Lys

<220>
<221>  VARIANT
<222>  (27)..(27)
<223>  Xaa=methionine, norleucine, methionine sulfoxide, or 
       O-methyl-L-homoserine

<220>
<221>  VARIANT
<222>  (31)..(31)
<223>  Xaa=optional, but when present is one or more gamma glutamic acid
       residues

<400>  1907

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Xaa Tyr Leu Asp Xaa 
1               5                   10                  15      


Xaa Xaa Ala Xaa Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1908
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa = D-Ser,  Aib,  Acb, Acx,  Abu, D-Abu, Aminovaleric acid 
       (Nva), Cpa, Prg, Alg, 2-Cha, D-tbg, Vg, Acp, or Acpe

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Tyr or Lys

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Xaa=Ser or Lys

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa=Ser or Lys

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Xaa=Arg or Glu

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa=Arg or Ala

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa=Gln or Lys

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=methionine, norleucine, methionine sulfoxide, or 
       O-methyl-L-homoserine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  optional, but when present one or more gamma glutamic acid 
       residues

<400>  1908

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Xaa Tyr Leu Asp Xaa 
1               5                   10                  15      


Xaa Xaa Ala Xaa Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1909
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog

<400>  1909

His Ser Gln Gly Thr Phe Thr Ser Asp Ser Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys 
            20                  25                  30  


<210>  1910
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine, Aib, Acb, Acx, Abu, D-Abu,  Aminovaleric acid 
       (Nva), Cpa, Prg, Alg, 2-Cha, D-tbg, Vg, Acp, or Acpe

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Tyr or Lys

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Xaa=Ser or Lys

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa=Ser, aib,  or Glu

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Xaa=Arg or Glu

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa=Arg or Ala

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa=Glu or Lys

<220>
<221>  MOD_RES
<222>  (27)..(27)
<223>  Xaa=Met, norleucine, methionine sulfoxide, or 
       O-methyl-L-homoserine

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (32)..(32)
<223>  Xaa=is optional but when present, it is gamma-glutamic acid

<400>  1910

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Xaa Tyr Leu Asp Xaa 
1               5                   10                  15      


Xaa Xaa Ala Xaa Asp Phe Val Gln Trp Leu Xaa Asn Thr Lys Xaa Xaa 
            20                  25                  30          


<210>  1911
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa=Aib

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1911

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Glu Xaa 
            20                  25                  30      


<210>  1912
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa=aib

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Xaa=D-Lys

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1912

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Xaa Xaa 
            20                  25                  30      


<210>  1913
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1913

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1914
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa=aib

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-D-glutamic acid

<400>  1914

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Glu Xaa 
            20                  25                  30      


<210>  1915
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(glutamic acid-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1915

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1916
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(Arg-Arg-palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1916

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1917
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-Serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(homocysteic acid-homocysteic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1917

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1918
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-Serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(D-glutamic acid-D-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1918

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1919
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-Serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-myristoyl)

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa=aib

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1919

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1920
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-Serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-palmitoyl)

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa=aib

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1920

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Thr Lys Xaa 
            20                  25                  30      


<210>  1921
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  OXM analog


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa=D-Serine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Xaa=Lys(gamma-glutamic acid-gamma-glutamic acid-stearoyl)

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa=aib

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa=gamma-glutamic acid

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  1921

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Xaa 
            20                  25                  30      


<210>  1922

<400>  1922
000

<210>  1923

<400>  1923
000

<210>  1924

<400>  1924
000

<210>  1925

<400>  1925
000

<210>  1926

<400>  1926
000

<210>  1927

<400>  1927
000

<210>  1928

<400>  1928
000

<210>  1929

<400>  1929
000

<210>  1930

<400>  1930
000

<210>  1931

<400>  1931
000

<210>  1932

<400>  1932
000

<210>  1933

<400>  1933
000

<210>  1934

<400>  1934
000

<210>  1935

<400>  1935
000

<210>  1936

<400>  1936
000

<210>  1937

<400>  1937
000

<210>  1938

<400>  1938
000

<210>  1939

<400>  1939
000

<210>  1940

<400>  1940
000

<210>  1941

<400>  1941
000

<210>  1942

<400>  1942
000

<210>  1943

<400>  1943
000

<210>  1944

<400>  1944
000

<210>  1945

<400>  1945
000

<210>  1946

<400>  1946
000

<210>  1947

<400>  1947
000

<210>  1948

<400>  1948
000

<210>  1949

<400>  1949
000

<210>  1950

<400>  1950
000

<210>  1951

<400>  1951
000

<210>  1952

<400>  1952
000

<210>  1953

<400>  1953
000

<210>  1954

<400>  1954
000

<210>  1955

<400>  1955
000

<210>  1956

<400>  1956
000

<210>  1957

<400>  1957
000

<210>  1958

<400>  1958
000

<210>  1959

<400>  1959
000

<210>  1960

<400>  1960
000

<210>  1961

<400>  1961
000

<210>  1962

<400>  1962
000

<210>  1963

<400>  1963
000

<210>  1964

<400>  1964
000

<210>  1965

<400>  1965
000

<210>  1966

<400>  1966
000

<210>  1967

<400>  1967
000

<210>  1968

<400>  1968
000

<210>  1969

<400>  1969
000

<210>  1970

<400>  1970
000

<210>  1971

<400>  1971
000

<210>  1972

<400>  1972
000

<210>  1973

<400>  1973
000

<210>  1974

<400>  1974
000

<210>  1975

<400>  1975
000

<210>  1976

<400>  1976
000

<210>  1977

<400>  1977
000

<210>  1978

<400>  1978
000

<210>  1979

<400>  1979
000

<210>  1980

<400>  1980
000

<210>  1981

<400>  1981
000

<210>  1982

<400>  1982
000

<210>  1983

<400>  1983
000

<210>  1984

<400>  1984
000

<210>  1985

<400>  1985
000

<210>  1986

<400>  1986
000

<210>  1987

<400>  1987
000

<210>  1988

<400>  1988
000

<210>  1989

<400>  1989
000

<210>  1990

<400>  1990
000

<210>  1991

<400>  1991
000

<210>  1992

<400>  1992
000

<210>  1993

<400>  1993
000

<210>  1994

<400>  1994
000

<210>  1995

<400>  1995
000

<210>  1996

<400>  1996
000

<210>  1997

<400>  1997
000

<210>  1998

<400>  1998
000

<210>  1999

<400>  1999
000

<210>  2000

<400>  2000
000

<210>  2001
<211>  29
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Wild type glucagon

<400>  2001

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2002
<211>  42
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Native human GIP

<220>
<221>  CHAIN
<222>  (1)..(42)

<400>  2002

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Asp Trp Lys His Asn Ile Thr Gln 
        35                  40          


<210>  2003
<211>  30
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(30)
<223>  GLP-1(7-36) amidated

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  2003

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  2004
<211>  31
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(31)
<223>  GLP-1(7-37)

<400>  2004

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg Gly 
            20                  25                  30      


<210>  2005
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2005

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  2006
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2006

Gly Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10      


<210>  2007
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2007

Lys Arg Asn Arg Asn Asn Ile Ala 
1               5               


<210>  2008
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2008

Lys Arg Asn Arg 
1               


<210>  2009
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2009

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
1               5                   10      


<210>  2010
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2010

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2011
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2011

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2012
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2012

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2013
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2013

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2014
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2014

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Glu Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2015
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2015

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2016
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2016

His Xaa Gln Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2017
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2017

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ala Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2018
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2018

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2019
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2019

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala His Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2020
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2020

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2021
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2021

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2022
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2022

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Ala 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2023
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2023

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Xaa Ala Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2024
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2024

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2025
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2025

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp His 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2026
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2026

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2027
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2027

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Xaa Lys Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2028
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2028

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


His Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2029
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2029

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2030
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2030

His Xaa Ile Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2031
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2031

His Xaa Met Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2032
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2032

His Xaa Leu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2033
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Homoserine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2033

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2034
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acetyl ornithine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2034

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2035
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2035

His Xaa Ala Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2036
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acetyl diaminobutanoic acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2036

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2037
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2037

His Xaa Val Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2038
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is norvaline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2038

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2039
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acetyl lysine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2039

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2040
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is norleucine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2040

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2041
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is methionine sulfone

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2041

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2042
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is methionine sulfoxide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2042

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2043
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2043

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2044
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2044

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2045
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2045

His Xaa Val Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2046
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is methionine sulfoxide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2046

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2047
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is norvaline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2047

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2048
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is homoserine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2048

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2049
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2049

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Ala Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2050
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2050

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Ala Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2051
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2051

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2052
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2052

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2053
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2053

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Ala Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2054
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2054

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Ala Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2055
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2055

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ala 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2056
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2056

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ala Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2057
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2057

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Ala Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2058
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2058

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Ala Pro Pro Ser Lys Gly 
        35                  40      


<210>  2059
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2059

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Ala Pro Ser Lys Gly 
        35                  40      


<210>  2060
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2060

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Ala Ser Lys Gly 
        35                  40      


<210>  2061
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2061

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ala Lys Gly 
        35                  40      


<210>  2062
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2062

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2063
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2063

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Val Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2064
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2064

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2065
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2065

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2066
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently attached to a C12 to C18 
       acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is an acidic amino acid, optionally, Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser; e.g., Glu, Ala, alpha, alpha-disubstituted amino 
       acid (e.g., AIB), His, Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa is Arg, His, Gln

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Ala or alpha, alpha disubstituted amino acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is selected from group consisting of: alpha, 
       alpha-disubstituted amino acid (e.g., AIB) or Gln or His, Lys, or
       Ala

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid (optionally, Asp or Glu)

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is aliphatic, e.g., Ala or Gly or AIB or Val

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  Xaa is a small aliphatic amino acid, e.g., Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid (optionally, Arg or Lys)

<400>  2066

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Xaa Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  2067
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is an amino acid comprising a side chain imidazole, 
       optionally, a His or His derivative

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is a DPP-IV protetive amino acid, optionally, an alpha, 
       alpha-disubstituted amino acid (e.g., AIB)

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is selected from the group consisting of Glu, Ala, Leu, Ile, 
       Nle, Val, NorVal, homoserine, Met, methionine sulfoxide, 
       methionine sulfone, acetyl-Orn, acetyl-diaminobutanoic acid, 
       acetyl-Lys

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is an amino acid covalently attached to a C12 to C18 acyl or 
       alkyl group

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is an acidic amino acid, optionally, Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser; (e.g., Glu, Ala, alpha, alpha-disubstituted amino 
       acid (e.g., AIB), His, Lys)

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa is Arg, His, Gln

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Ala or alpha, alpha disubstituted amino acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is selected from group consisting of: alpha, 
       alpha-disubstituted amino acid (e.g., AIB) or Gln or His, Lys, or
       Ala

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid (optionally, Asp or Glu)

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is aliphatic, e.g., Ala or Gly or AIB or Val

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  Xaa is a small aliphatic amino acid, e.g., Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid (optionally, Arg or Lys)

<400>  2067

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Xaa Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  2068
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2068

Gly Pro Ser Ser Gly Arg Pro Pro Pro Ser 
1               5                   10  


<210>  2069
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2069

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Xaa Glu 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Gln Trp Leu Leu Xaa Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2070
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Glu, Ala, Leu, Ile, Nle, Val, NorVal, homoserine, Met, 
       methionine sulfoxide, methionine sulfone, acetyl-Orn, 
       acetyl-diaminobutanoic acid, acetyl-Lys

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2070

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Xaa Glu 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Gln Trp Leu Leu Xaa Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2071
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acidic amino acid, basic amino acid, or hydrophobic amino 
       acid, optionally, Glu, Nle, or Orn

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently attached to a C12 to C18 
       acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is an acidic amino acid, optionally, Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser; e.g., Glu, Ala, alpha, alpha-disubstituted amino 
       acid (e.g., AIB), His, Lys or Glu

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa is Arg, His, Gln

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is Ala or alpha, alpha disubstituted amino acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is selected from group consisting of: alpha, 
       alpha-disubstituted amino acid (e.g., AIB) or Gln or His, Lys, or
       Ala

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid (optionally, Asp or Glu)

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is aliphatic, e.g., Ala or Gly or AIB or Val

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  Xaa is a small aliphatic amino acid, e.g., Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid (optionally, Arg or Lys)

<400>  2071

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Xaa Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  2072
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acidic amino acid, basic amino acid, or hydrophobic amino 
       acid, optionally, Glu, Nle, or Orn

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Glu or Asp

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2072

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Xaa Glu 
1               5                   10                  15      


Arg Arg Ala Gln Xaa Phe Val Gln Trp Leu Leu Xaa Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2073

<400>  2073
000

<210>  2074

<400>  2074
000

<210>  2075

<400>  2075
000

<210>  2076

<400>  2076
000

<210>  2077

<400>  2077
000

<210>  2078

<400>  2078
000

<210>  2079

<400>  2079
000

<210>  2080

<400>  2080
000

<210>  2081

<400>  2081
000

<210>  2082

<400>  2082
000

<210>  2083

<400>  2083
000

<210>  2084

<400>  2084
000

<210>  2085

<400>  2085
000

<210>  2086

<400>  2086
000

<210>  2087

<400>  2087
000

<210>  2088

<400>  2088
000

<210>  2089

<400>  2089
000

<210>  2090

<400>  2090
000

<210>  2091

<400>  2091
000

<210>  2092

<400>  2092
000

<210>  2093

<400>  2093
000

<210>  2094

<400>  2094
000

<210>  2095

<400>  2095
000

<210>  2096

<400>  2096
000

<210>  2097

<400>  2097
000

<210>  2098

<400>  2098
000

<210>  2099

<400>  2099
000

<210>  2100
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #29

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2100

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2101
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #30

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2101

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2102
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #34

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  2102

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2103
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #36

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2103

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2104
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #37

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2104

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2105
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #44

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is alpha-dimethyl imidiazole acetic acid (DMIA)

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2105

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2106
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #49

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2106

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2107
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #53

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide acid
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2107

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Val Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2108
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #54

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide acid
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2108

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Lys Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2109
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #61

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2109

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2110
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #62

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2110

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2111
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #63

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2111

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2112
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #64

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2112

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2113
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #65

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2113

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2114
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2114

His Xaa Gln Gly Thr Phe Thr Ser Lys Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2115
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2115

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2116
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2116

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2117
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2117

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2118
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2118

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2119
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2119

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2120
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2120

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2121
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2121

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2122
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Covalently bound to a PEG

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2122

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  2123
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2123

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2124
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2124

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2125
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2125

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2126
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  2126

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2127
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amiation

<400>  2127

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2128
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2128

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2129
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptid


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2129

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2130
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2130

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2131
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2131

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2132
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2132

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2133
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2133

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2134
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2134

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2135
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptid


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2135

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2136
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2136

His Xaa Glu Gly Thr Phe Ile Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2137
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2137

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2138
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2138

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2139
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2139

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2140
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2140

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2141
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2141

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2142
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2142

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2143
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #29

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acid amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2143

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2144
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #30

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acid amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2144

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2145
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #34

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  2145

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2146
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #36

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2146

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2147
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #37

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2147

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2148
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #44

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is alpha-dimethyl imidiazole acetic acid (DMIA)

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2148

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2149
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #49

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2149

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2150
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #53

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2150

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Val Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2151
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #54

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2151

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Lys Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2152
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #61

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2152

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2153
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #62

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2153

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2154
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #63

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2154

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2155
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #64

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2155

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2156
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #65

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2156

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2157
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2157

His Xaa Gln Gly Thr Phe Thr Ser Lys Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2158
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2158

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2159
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2159

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2160
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2160

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2161
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2161

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2162
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2162

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2163
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2163

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2164
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2164

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2165
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2165

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  2166
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2166

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2167
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2167

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2168
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  2168

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2169
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  2169

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2170
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2170

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2171
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2171

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2172
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2172

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2173
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2173

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2174
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2174

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2175
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2175

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2176
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2176

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2177
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2177

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2178
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2178

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2179
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2179

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2180
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2180

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2181
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2181

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2182
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  mt-261

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C12-C18 fatty acyl group covalently attached Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2182

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2183
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  mt-278

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C12-C18 fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2183

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2184
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-384

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2184

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2185
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-384

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2185

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2186
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2186

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2187
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2187

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2188
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covantly bound to a C12-C18 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2188

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2189
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 succinoyl via a beta-Ala spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2189

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2190
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2190

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2191
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound a C12-C18 fatty acyl group via 
       dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2191

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2192
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe is covalently bound to a C12-C18 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2192

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2193
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  4-amino-Phe covalently bound to a C12-C18 fatty acyl group via 
       dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2193

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Gly 
        35                  40      


<210>  2194
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Xaa is 4-amino Phe

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  4-amino Phe covalently bound to C12-C18 succinoyl

<220>
<221>  MOD_RES
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2194

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Gly 
        35                  40      


<210>  2195
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  4-amino-Phe covalently bound to a C12-C18 fatty acyl group via 
       acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2195

His Xaa Gln Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2196
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound to a C12-C18 fatty acyl group via 
       acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2196

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2197
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  4-amino-Phe covalently bound to a C12-C18 fatty acyl group via 
       acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2197

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Xaa Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2198
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound to C12-C18 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2198

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2199
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2199

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Lys Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2200
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2200

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Lys Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2201
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2201

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2202
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2202

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2203
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2203

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2204
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2204

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2205
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 fatty acyl group via a spacer 
       comprising an amido miniPEG acid and an acidic amino acid, 
       wherein the amido miniPEG acid has a structure {-N- CH2- 
       CH2-[-O-CH2-CH2-]n-COO-}, wherein n is 2

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2205

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2206
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising an amido miniPEG acid and an acidic amino acid, 
       wherein the amido miniPEG acid has a structure {-N- CH2- 
       CH2-[-O-CH2-CH2-]n-COO-}, wherein n is 4

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2206

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2207
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising an amido miniPEG acid and an acidic amino acid, 
       wherein the amido miniPEG acid has a structure {-N- CH2- 
       CH2-[-O-CH2-CH2-]n-COO-}, wherein n is 8

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2207

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2208
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is 
       attached to two C12-C18 fatty acyl groups, wherein each C12-C18 
       fatty acyl group is attached to the Lys spacer via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2208

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2209
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is 
       attached to two C12-C18 fatty acyl groups, wherein each C12-C18 
       fatty acyl group is attached to the Lys spacer via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2209

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2210
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group, which is 
       covalently bound to a acid amino acid spacer, which is covalently
       bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2210

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2211
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2211

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2212
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is covalently bound to an acidic 
       amino acid spacer, which is covalently bound to C12-C18 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2212

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2213
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys spacer, which is bound to an acid amino 
       acid spacer, which is bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to SEQ ID NO 212 via Cys spacer which is 
       disulfide bonded to a 2nd Cys, which the 2nd Cys is bound to Lys 
       at position 40 of SEQ ID NO 212 and is bound to an acid amino 
       acid spacer, which, in turn is bound to C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2213

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2214
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is bound to an acidic amino acid 
       spacer, which is bound to C16 fatty acyl group and the sulfer of 
       the Cys is thioether linked to a peptide of SEQ ID NO: 282 via 
       Lys at position 40

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2214

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2215
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is bound to an acidic amino acid 
       spacer, which is bound to C12-C18 fatty acyl group, and the 
       sulfur of the Cys is disulfide bonded to a 2nd Cys, which the 2nd
       Cys is bound to a peptide of SEQ ID NO: 282 via Lys at position

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2215

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2216
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2216

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2217
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2217

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2218
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2218

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2219
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2219

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2220
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2220

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2221
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2221

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2222
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is absent or is Gly (e.g. when position 10 is not Tyr) or is 
       an amino acid covalently bound to a C10-C26 acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Optionally present, when residue at position 40 is an amino acid 
       covalently bound to C10-C26 acyl or alkyl group, Xaa is Gly

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2222

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Xaa Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser Xaa Xaa 
        35                  40      


<210>  2223
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is absent or is Gly (e.g. when position 10 is not Tyr) or is 
       an amino acid covalently bound to a C10-C26 acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Optionally present, when residue at position 40 is an amino acid 
       covalently bound to C10-C26 acyl or alkyl group then Xaa is Gly

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2223

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Xaa 
        35                  40      


<210>  2224
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2224

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2225
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(29)
<223>  At least one amino acid is an amino acid covalently bound to a 
       C10 to C26 acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Lys or Tyr

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Thr or Gly

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2225

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Asp Xaa 
            20                  25                  


<210>  2226
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Lys covalently bound to a C10-C26 acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2226

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Asp Xaa 
            20                  25                  


<210>  2227
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C12-C18 acyl or
       alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid, optionally, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2227

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  2228
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently attached to a C12 to C18 
       acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, an alpha, alpha disubstituted amino acid or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2228

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2229
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently attached to a C10 to C26 
       acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2229

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2230
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, alpha, alpha-disubstituted amino acid, or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2230

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2231
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is an acidic, basic or hydrophobic amino acid, optionally, 
       Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C12 to C18 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa can be any amino acid, optionally any amino acid other than 
       Gly, Pro or Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid, optionally, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2231

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  2232
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently attached to a C12 to C18 
       acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, an alpha, alpha disubstituted amino acid or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2232

His Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2233
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is an acidic, basic or hydrophobic amino acid, optionally, is
       Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2233

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2234
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, alpha, alpha-disubstituted amino acid, or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2234

His Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2235
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C12 to C18 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid, optionally, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2235

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  2236
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C12 to C18 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, an alpha, alpha disubstituted amino acid or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2236

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2237
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2237

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2238
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, alpha, alpha-disubstituted amino acid, or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2238

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2239
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2239

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2240
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2240

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2241
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2241

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  2242
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2242

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Arg Pro Pro Pro Ser 
        35                  


<210>  2243
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2243

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  2244
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Lys spacer, wherein Lys spacer is bound via 
       alpha amine to an acidic amino acid spacer, which is bound to 
       C12-C18 fatty acyl group and Lys spacer is bound via epsilon 
       amine to an acidic amino acid which is bound to C12-C18 fatty

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2244

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2245
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is bound
       to C12-C18 fatty acyl group via an acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2245

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2246
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is bound
       to (1) C12-C18 fatty acyl group via an acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2246

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2247
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12-C18 fatty acyl group via side chain 
       hydroxyl of Tyr

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2247

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Tyr Gly 
        35                  40      


<210>  2248
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-345

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C12-C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2248

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2249
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-347

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C12-C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2249

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2250
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-349

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C12-C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2250

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2251
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-351

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C12-C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2251

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2252
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-364

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C12-C18 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2252

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2253
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound a C12-C18 fatty acyl group via 
       spacer comprising two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2253

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2254
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  4-amino-Phe covalently bound to a C12-C18 fatty acyl group via 
       spacer comprising two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2254

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Gly 
        35                  40      


<210>  2255
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  4-amino-Phe covalently bound to C12-C18 fatty acyl group via 
       spacer comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2255

His Xaa Gln Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2256
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound to a C12-C18 fatty acyl group via 
       spacer comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2256

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2257
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  4-amino-Phe covalently bound to a C12-C18 fatty acyl group via 
       spacer comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2257

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Xaa Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2258
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising acidic residue

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2258

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Lys Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2259
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2259

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Lys Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2260
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2260

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2261
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2261

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2262
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2262

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2263
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via a spacer 
       comprising an amido miniPEG acid and an acidic amino acid, 
       wherein the amido miniPEG acid has a structure {-N- CH2- 
       CH2-[-O-CH2-CH2-]n-COO-}, wherein n is 2

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2263

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2264
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising an amido miniPEG acid and an acidic amino acid, 
       wherein the amido miniPEG acid has a structure {-N- CH2- 
       CH2-[-O-CH2-CH2-]n-COO-}, wherein n is 4

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2264

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2265
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising an amido miniPEG acid and an acidic amino acid, 
       wherein the amido miniPEG acid has a structure {-N- CH2- 
       CH2-[-O-CH2-CH2-]n-COO-}, wherein n is 8

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2265

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2266
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is 
       attached to two C12-C18 fatty acyl groups, wherein each C12-C18 
       fatty acyl group is attached to the Lys spacer via spacer 
       comprising an acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2266

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2267
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is 
       attached to two C12-C18 fatty acyl groups, wherein each C12-C18 
       fatty acyl group is attached to the Lys spacer via spacer 
       comprising an acidic residue

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2267

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2268
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group, which is 
       covalently bound to a spacer comprising an acidic residue, which 
       is covalently bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2268

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2269
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising an acidic residue

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2269

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2270
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is covalently bound to an acidic 
       residue, which is covalently bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2270

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2271
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys spacer, which is bound to an acidic 
       residue, which is bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to SEQ ID 270 via Cys spacer which is disulfide 
       bonded to a 2nd Cys, which the 2nd Cys is bound to Lys at 
       position 40 of SEQ ID 270 and is bound to an acidic residue, 
       which, in turn is bound to a C12-C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2271

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2272
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is bound to an acidic residue, 
       which is bound to a C12-C18 fatty acyl group and the sulfer of 
       the Cys is thioether linked to a peptide of SEQ ID NO: 282 via 
       Lys at position 40

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2272

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2273
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is bound to an acidic residue, 
       which is bound to a C12-C18 fatty acyl group, and the sulfur of 
       the Cys is disulfide bonded to a 2nd Cys, which the 2nd Cys is 
       bound to a peptide of SEQ ID NO: 282 via Lys at position 40

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2273

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2274
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2274

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2275
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2275

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2276
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2276

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2277
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2277

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2278
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising an acidic residue

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2278

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  2279
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising an acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2279

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Arg Pro Pro Pro Ser 
        35                  


<210>  2280
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via spacer 
       comprising two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2280

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  2281
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Lys spacer, wherein Lys spacer is bound via 
       the alpha amine to an acidic residue spacer, which is bound to 
       C12-C18 fatty acyl group and Lys spacer is bound via epsilon 
       amine to an acidic residue which is bound to C12-C18 fatty acyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2281

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2282
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2282

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2283
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2283

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2284
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2284

His Xaa Gln Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2285
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2285

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ala Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2286
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2286

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Arg Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2287
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2287

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala His Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2288
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2288

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2289
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2289

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2290
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2290

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Ala 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2291
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2291

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Xaa Ala Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2292
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2292

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2293
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2293

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp His 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2294
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2294

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2295
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2295

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Xaa Lys Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2296
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2296

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


His Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2297
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2297

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2298
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2298

His Xaa Ile Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2299
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2299

His Xaa Met Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2300
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2300

His Xaa Leu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2301
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Homoserine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2301

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2302
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acetyl ornithine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2302

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2303
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2303

His Xaa Ala Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2304
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acetyl diaminobutanoic acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2304

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2305
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2305

His Xaa Val Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2306
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is norvaline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2306

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2307
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acetyl lysine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2307

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2308
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is norleucine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2308

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2309
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is methionine sulfone

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2309

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2310
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is methionine sulfoxide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2310

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2311
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2311

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2312
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2312

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2313
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2313

His Xaa Val Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2314
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is methionine sulfoxide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2314

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2315
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is norvaline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2315

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2316
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is homoserine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2316

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2317
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2317

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Ala Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2318
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2318

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Ala Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2319
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2319

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2320
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2320

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2321
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2321

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Ala Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2322
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2322

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Ala Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2323
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2323

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ala 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2324
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2324

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ala Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2325
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2325

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Ala Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2326
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2326

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Ala Pro Pro Ser Lys Gly 
        35                  40      


<210>  2327
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2327

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Ala Pro Ser Lys Gly 
        35                  40      


<210>  2328
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2328

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Ala Ser Lys Gly 
        35                  40      


<210>  2329
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C12-C18 fatty acyl group via dipeptide 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2329

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ala Lys Gly 
        35                  40      


<210>  2330
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2330

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Val Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2331
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2331

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2332
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12-C18 fatty acyl group via acidic amino 
       acid spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2332

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2333
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #29

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2333

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2334
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #30

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2334

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2335
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #34

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  2335

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2336
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #36

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2336

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2337
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #37

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2337

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2338
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #44

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is alpha-dimethyl imidiazole acetic acid (DMIA)

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2338

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2339
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #49

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2339

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2340
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #53

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2340

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Val Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2341
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #54

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2341

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Lys Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2342
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #61

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2342

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2343
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #62

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2343

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2344
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #63

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2344

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2345
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #64

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2345

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2346
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #65

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2346

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2347
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2347

His Xaa Gln Gly Thr Phe Thr Ser Lys Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2348
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2348

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2349
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2349

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2350
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2350

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2351
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2351

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2352
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2352

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2353
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2353

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2354
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2354

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2355
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Covalently bound to a PEG

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2355

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  2356
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2356

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2357
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2357

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2358
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2358

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2359
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  2359

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2360
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amiation

<400>  2360

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2361
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2361

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2362
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2362

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2363
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2363

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2364
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2364

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2365
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2365

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2366
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2366

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2367
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2367

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2368
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2368

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2369
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2369

His Xaa Glu Gly Thr Phe Ile Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2370
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2370

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2371
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2371

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2372
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2372

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2373
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2373

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2374
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2374

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2375
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2375

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2376
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #29

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2376

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2377
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #30

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2377

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2378
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #34

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  2378

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2379
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #36

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2379

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2380
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #37

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2380

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2381
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #44

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is alpha-dimethyl imidiazole acetic acid (DMIA)

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2381

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2382
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #49

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2382

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2383
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #53

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2383

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Val Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2384
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #54

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2384

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Lys Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2385
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #61

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2385

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2386
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #62

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2386

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2387
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #63

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2387

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2388
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #64

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2388

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2389
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #65

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2389

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2390
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2390

His Xaa Gln Gly Thr Phe Thr Ser Lys Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2391
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2391

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2392
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2392

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2393
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2393

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2394
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2394

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2395
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2395

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2396
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2396

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2397
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2397

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2398
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2398

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  2399
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2399

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2400
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2400

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  2401
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  2401

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2402
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amiation

<400>  2402

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  2403
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2403

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2404
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2404

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2405
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2405

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2406
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2406

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2407
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2407

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2408
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2408

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2409
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2409

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2410
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2410

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2411
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2411

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2412
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2412

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2413
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2413

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2414
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2414

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Thr 
            20                  25                  


<210>  2415
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  mt-261

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2415

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2416
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  mt-278

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2416

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2417
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-384

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2417

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2418
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-384

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2418

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2419
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2419

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2420
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2420

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2421
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2421

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2422
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2422

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2423
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2423

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2424
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2424

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2425
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2425

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2426
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2426

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Gly 
        35                  40      


<210>  2427
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Xaa is 4-amino Phe

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MOD_RES
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2427

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Gly 
        35                  40      


<210>  2428
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2428

His Xaa Gln Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2429
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2429

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2430
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2430

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Xaa Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2431
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2431

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2432
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2432

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Lys Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2433
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2433

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Lys Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2434
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2434

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2435
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2435

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2436
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2436

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2437
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2437

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2438
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2438

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2439
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2439

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2440
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2440

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2441
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2441

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2442
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2442

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2443
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2443

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2444
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2444

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2445
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2445

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2446
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2446

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2447
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2447

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2448
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2448

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2449
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2449

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2450
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2450

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2451
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2451

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2452
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2452

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2453
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2453

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2454
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2454

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2455
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is absent or is Gly (e.g. when position 10 is not Tyr) or is 
       an amino acid acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Xaa is any amino acid and is optionally present when residue at 
       position 40 is an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2455

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Xaa Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser Xaa Xaa 
        35                  40      


<210>  2456
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is absent or is Gly (e.g. when position 10 is not Tyr) or is 
       an amino acid acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Xaa is any amino acid and is optionally present when residue at 
       position 40 is an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2456

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Xaa 
        35                  40      


<210>  2457
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2457

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2458
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(29)
<223>  At least one amino acid is an amino acid acylated or alkylated, 
       optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Lys or Tyr

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Thr or Gly

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2458

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Asp Xaa 
            20                  25                  


<210>  2459
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Lys acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2459

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Asp Xaa 
            20                  25                  


<210>  2460
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid, optionally, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2460

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  2461
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, an alpha, alpha disubstituted amino acid or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2461

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2462
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2462

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2463
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, alpha, alpha-disubstituted amino acid, or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2463

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2464
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is an acidic, basic or hydrophobic amino acid, optionally, 
       Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa can be any amino acid, optionally any amino acid other than 
       Gly, Pro or Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid, optionally, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2464

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  2465
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, an alpha, alpha disubstituted amino acid or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2465

His Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2466
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is an acidic, basic or hydrophobic amino acid, optionally, is
       Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2466

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2467
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, alpha, alpha-disubstituted amino acid, or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2467

His Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2468
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid, optionally, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2468

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  2469
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, an alpha, alpha disubstituted amino acid or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2469

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2470
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2470

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2471
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid acylated or alkylated, optionally, 
       via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, alpha, alpha-disubstituted amino acid, or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  2471

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  2472
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2472

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2473
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2473

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2474
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2474

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  2475
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2475

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Arg Pro Pro Pro Ser 
        35                  


<210>  2476
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2476

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  2477
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2477

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2478
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2478

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2479
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2479

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2480
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2480

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Tyr Gly 
        35                  40      


<210>  2481
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-345

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2481

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2482
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-347

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2482

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2483
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-349

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2483

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2484
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-351

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2484

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2485
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-364

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2485

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2486
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2486

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2487
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2487

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Gly 
        35                  40      


<210>  2488
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2488

His Xaa Gln Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2489
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2489

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2490
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2490

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Xaa Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2491
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2491

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Lys Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2492
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2492

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Lys Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2493
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2493

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2494
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2494

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2495
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2495

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2496
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2496

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2497
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2497

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2498
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2498

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2499
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2499

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2500
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2500

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2501
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2501

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2502
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2502

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  2503
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2503

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2504
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2504

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2505
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2505

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2506
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2506

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2507
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2507

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2508
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2508

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2509
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2509

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2510
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2510

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2511
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2511

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  2512
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2512

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Arg Pro Pro Pro Ser 
        35                  


<210>  2513
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  2513

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  2514
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2514

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2515
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2515

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2516
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2516

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2517
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2517

His Xaa Gln Gly Thr Phe Thr Ser Glu Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2518
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2518

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ala Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2519
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2519

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Arg Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2520
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2520

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala His Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2521
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2521

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2522
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2522

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2523
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2523

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Ala 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2524
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2524

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Xaa Ala Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2525
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2525

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2526
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2526

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp His 
1               5                   10                  15      


Arg Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2527
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2527

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2528
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2528

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Xaa Lys Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2529
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2529

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


His Ala Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2530
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2530

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2531
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2531

His Xaa Ile Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2532
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2532

His Xaa Met Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2533
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2533

His Xaa Leu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2534
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Homoserine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2534

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2535
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acetyl ornithine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2535

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2536
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2536

His Xaa Ala Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2537
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acetyl diaminobutanoic acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2537

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2538
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2538

His Xaa Val Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2539
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is norvaline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2539

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2540
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is acetyl lysine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2540

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2541
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is norleucine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2541

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2542
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is methionine sulfone

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2542

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2543
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is methionine sulfoxide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2543

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2544
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2544

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2545
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2545

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2546
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2546

His Xaa Val Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2547
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is methionine sulfoxide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2547

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2548
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is norvaline

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2548

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2549
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is homoserine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2549

His Xaa Xaa Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2550
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2550

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Ala Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2551
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2551

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Ala Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2552
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2552

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2553
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2553

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2554
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2554

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Ala Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2555
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2555

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Ala Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2556
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2556

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ala 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2557
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2557

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ala Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2558
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2558

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Ala Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  2559
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2559

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Ala Pro Pro Ser Lys Gly 
        35                  40      


<210>  2560
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2560

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Ala Pro Ser Lys Gly 
        35                  40      


<210>  2561
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2561

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Ala Ser Lys Gly 
        35                  40      


<210>  2562
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  2562

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ala Lys Gly 
        35                  40      


<210>  2563
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2563

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Val Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2564
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2564

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2565
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated or alkylated, optionally, via a spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  2565

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  2566

<400>  2566
000

<210>  2567

<400>  2567
000

<210>  2568

<400>  2568
000

<210>  2569

<400>  2569
000

<210>  2570

<400>  2570
000

<210>  2571

<400>  2571
000

<210>  2572

<400>  2572
000

<210>  2573

<400>  2573
000

<210>  2574

<400>  2574
000

<210>  2575

<400>  2575
000

<210>  2576

<400>  2576
000

<210>  2577

<400>  2577
000

<210>  2578

<400>  2578
000

<210>  2579

<400>  2579
000

<210>  2580

<400>  2580
000

<210>  2581

<400>  2581
000

<210>  2582

<400>  2582
000

<210>  2583

<400>  2583
000

<210>  2584

<400>  2584
000

<210>  2585

<400>  2585
000

<210>  2586

<400>  2586
000

<210>  2587

<400>  2587
000

<210>  2588

<400>  2588
000

<210>  2589

<400>  2589
000

<210>  2590

<400>  2590
000

<210>  2591

<400>  2591
000

<210>  2592

<400>  2592
000

<210>  2593

<400>  2593
000

<210>  2594

<400>  2594
000

<210>  2595

<400>  2595
000

<210>  2596

<400>  2596
000

<210>  2597

<400>  2597
000

<210>  2598

<400>  2598
000

<210>  2599

<400>  2599
000

<210>  2600

<400>  2600
000

<210>  2601

<400>  2601
000

<210>  2602

<400>  2602
000

<210>  2603

<400>  2603
000

<210>  2604

<400>  2604
000

<210>  2605

<400>  2605
000

<210>  2606

<400>  2606
000

<210>  2607

<400>  2607
000

<210>  2608

<400>  2608
000

<210>  2609

<400>  2609
000

<210>  2610

<400>  2610
000

<210>  2611

<400>  2611
000

<210>  2612

<400>  2612
000

<210>  2613

<400>  2613
000

<210>  2614

<400>  2614
000

<210>  2615

<400>  2615
000

<210>  2616

<400>  2616
000

<210>  2617

<400>  2617
000

<210>  2618

<400>  2618
000

<210>  2619

<400>  2619
000

<210>  2620

<400>  2620
000

<210>  2621

<400>  2621
000

<210>  2622

<400>  2622
000

<210>  2623

<400>  2623
000

<210>  2624

<400>  2624
000

<210>  2625

<400>  2625
000

<210>  2626

<400>  2626
000

<210>  2627

<400>  2627
000

<210>  2628

<400>  2628
000

<210>  2629

<400>  2629
000

<210>  2630

<400>  2630
000

<210>  2631

<400>  2631
000

<210>  2632

<400>  2632
000

<210>  2633

<400>  2633
000

<210>  2634

<400>  2634
000

<210>  2635

<400>  2635
000

<210>  2636

<400>  2636
000

<210>  2637

<400>  2637
000

<210>  2638

<400>  2638
000

<210>  2639

<400>  2639
000

<210>  2640

<400>  2640
000

<210>  2641

<400>  2641
000

<210>  2642

<400>  2642
000

<210>  2643

<400>  2643
000

<210>  2644

<400>  2644
000

<210>  2645

<400>  2645
000

<210>  2646

<400>  2646
000

<210>  2647

<400>  2647
000

<210>  2648

<400>  2648
000

<210>  2649

<400>  2649
000

<210>  2650

<400>  2650
000

<210>  2651

<400>  2651
000

<210>  2652

<400>  2652
000

<210>  2653

<400>  2653
000

<210>  2654

<400>  2654
000

<210>  2655

<400>  2655
000

<210>  2656

<400>  2656
000

<210>  2657

<400>  2657
000

<210>  2658

<400>  2658
000

<210>  2659

<400>  2659
000

<210>  2660

<400>  2660
000

<210>  2661

<400>  2661
000

<210>  2662

<400>  2662
000

<210>  2663

<400>  2663
000

<210>  2664

<400>  2664
000

<210>  2665

<400>  2665
000

<210>  2666

<400>  2666
000

<210>  2667

<400>  2667
000

<210>  2668

<400>  2668
000

<210>  2669

<400>  2669
000

<210>  2670

<400>  2670
000

<210>  2671

<400>  2671
000

<210>  2672

<400>  2672
000

<210>  2673

<400>  2673
000

<210>  2674

<400>  2674
000

<210>  2675

<400>  2675
000

<210>  2676

<400>  2676
000

<210>  2677

<400>  2677
000

<210>  2678

<400>  2678
000

<210>  2679

<400>  2679
000

<210>  2680

<400>  2680
000

<210>  2681

<400>  2681
000

<210>  2682

<400>  2682
000

<210>  2683

<400>  2683
000

<210>  2684

<400>  2684
000

<210>  2685

<400>  2685
000

<210>  2686

<400>  2686
000

<210>  2687

<400>  2687
000

<210>  2688

<400>  2688
000

<210>  2689

<400>  2689
000

<210>  2690

<400>  2690
000

<210>  2691

<400>  2691
000

<210>  2692

<400>  2692
000

<210>  2693

<400>  2693
000

<210>  2694

<400>  2694
000

<210>  2695

<400>  2695
000

<210>  2696

<400>  2696
000

<210>  2697

<400>  2697
000

<210>  2698

<400>  2698
000

<210>  2699

<400>  2699
000

<210>  2700

<400>  2700
000

<210>  2701

<400>  2701
000

<210>  2702

<400>  2702
000

<210>  2703

<400>  2703
000

<210>  2704

<400>  2704
000

<210>  2705

<400>  2705
000

<210>  2706

<400>  2706
000

<210>  2707

<400>  2707
000

<210>  2708

<400>  2708
000

<210>  2709

<400>  2709
000

<210>  2710

<400>  2710
000

<210>  2711

<400>  2711
000

<210>  2712

<400>  2712
000

<210>  2713

<400>  2713
000

<210>  2714

<400>  2714
000

<210>  2715

<400>  2715
000

<210>  2716

<400>  2716
000

<210>  2717

<400>  2717
000

<210>  2718

<400>  2718
000

<210>  2719

<400>  2719
000

<210>  2720

<400>  2720
000

<210>  2721

<400>  2721
000

<210>  2722

<400>  2722
000

<210>  2723

<400>  2723
000

<210>  2724

<400>  2724
000

<210>  2725

<400>  2725
000

<210>  2726

<400>  2726
000

<210>  2727

<400>  2727
000

<210>  2728

<400>  2728
000

<210>  2729

<400>  2729
000

<210>  2730

<400>  2730
000

<210>  2731

<400>  2731
000

<210>  2732

<400>  2732
000

<210>  2733

<400>  2733
000

<210>  2734

<400>  2734
000

<210>  2735

<400>  2735
000

<210>  2736

<400>  2736
000

<210>  2737

<400>  2737
000

<210>  2738

<400>  2738
000

<210>  2739

<400>  2739
000

<210>  2740

<400>  2740
000

<210>  2741

<400>  2741
000

<210>  2742

<400>  2742
000

<210>  2743

<400>  2743
000

<210>  2744

<400>  2744
000

<210>  2745

<400>  2745
000

<210>  2746

<400>  2746
000

<210>  2747

<400>  2747
000

<210>  2748

<400>  2748
000

<210>  2749

<400>  2749
000

<210>  2750

<400>  2750
000

<210>  2751

<400>  2751
000

<210>  2752

<400>  2752
000

<210>  2753

<400>  2753
000

<210>  2754

<400>  2754
000

<210>  2755

<400>  2755
000

<210>  2756

<400>  2756
000

<210>  2757

<400>  2757
000

<210>  2758

<400>  2758
000

<210>  2759

<400>  2759
000

<210>  2760

<400>  2760
000

<210>  2761

<400>  2761
000

<210>  2762

<400>  2762
000

<210>  2763

<400>  2763
000

<210>  2764

<400>  2764
000

<210>  2765

<400>  2765
000

<210>  2766

<400>  2766
000

<210>  2767

<400>  2767
000

<210>  2768

<400>  2768
000

<210>  2769

<400>  2769
000

<210>  2770

<400>  2770
000

<210>  2771

<400>  2771
000

<210>  2772

<400>  2772
000

<210>  2773

<400>  2773
000

<210>  2774

<400>  2774
000

<210>  2775

<400>  2775
000

<210>  2776

<400>  2776
000

<210>  2777

<400>  2777
000

<210>  2778

<400>  2778
000

<210>  2779

<400>  2779
000

<210>  2780

<400>  2780
000

<210>  2781

<400>  2781
000

<210>  2782

<400>  2782
000

<210>  2783

<400>  2783
000

<210>  2784

<400>  2784
000

<210>  2785

<400>  2785
000

<210>  2786

<400>  2786
000

<210>  2787

<400>  2787
000

<210>  2788

<400>  2788
000

<210>  2789

<400>  2789
000

<210>  2790

<400>  2790
000

<210>  2791

<400>  2791
000

<210>  2792

<400>  2792
000

<210>  2793

<400>  2793
000

<210>  2794

<400>  2794
000

<210>  2795

<400>  2795
000

<210>  2796

<400>  2796
000

<210>  2797

<400>  2797
000

<210>  2798

<400>  2798
000

<210>  2799

<400>  2799
000

<210>  2800

<400>  2800
000

<210>  2801

<400>  2801
000

<210>  2802

<400>  2802
000

<210>  2803

<400>  2803
000

<210>  2804

<400>  2804
000

<210>  2805

<400>  2805
000

<210>  2806

<400>  2806
000

<210>  2807

<400>  2807
000

<210>  2808

<400>  2808
000

<210>  2809

<400>  2809
000

<210>  2810

<400>  2810
000

<210>  2811

<400>  2811
000

<210>  2812

<400>  2812
000

<210>  2813

<400>  2813
000

<210>  2814

<400>  2814
000

<210>  2815

<400>  2815
000

<210>  2816

<400>  2816
000

<210>  2817

<400>  2817
000

<210>  2818

<400>  2818
000

<210>  2819

<400>  2819
000

<210>  2820

<400>  2820
000

<210>  2821

<400>  2821
000

<210>  2822

<400>  2822
000

<210>  2823

<400>  2823
000

<210>  2824

<400>  2824
000

<210>  2825

<400>  2825
000

<210>  2826

<400>  2826
000

<210>  2827

<400>  2827
000

<210>  2828

<400>  2828
000

<210>  2829

<400>  2829
000

<210>  2830

<400>  2830
000

<210>  2831

<400>  2831
000

<210>  2832

<400>  2832
000

<210>  2833

<400>  2833
000

<210>  2834

<400>  2834
000

<210>  2835

<400>  2835
000

<210>  2836

<400>  2836
000

<210>  2837

<400>  2837
000

<210>  2838

<400>  2838
000

<210>  2839

<400>  2839
000

<210>  2840

<400>  2840
000

<210>  2841

<400>  2841
000

<210>  2842

<400>  2842
000

<210>  2843

<400>  2843
000

<210>  2844

<400>  2844
000

<210>  2845

<400>  2845
000

<210>  2846

<400>  2846
000

<210>  2847

<400>  2847
000

<210>  2848

<400>  2848
000

<210>  2849

<400>  2849
000

<210>  2850

<400>  2850
000

<210>  2851

<400>  2851
000

<210>  2852

<400>  2852
000

<210>  2853

<400>  2853
000

<210>  2854

<400>  2854
000

<210>  2855

<400>  2855
000

<210>  2856

<400>  2856
000

<210>  2857

<400>  2857
000

<210>  2858

<400>  2858
000

<210>  2859

<400>  2859
000

<210>  2860

<400>  2860
000

<210>  2861

<400>  2861
000

<210>  2862

<400>  2862
000

<210>  2863

<400>  2863
000

<210>  2864

<400>  2864
000

<210>  2865

<400>  2865
000

<210>  2866

<400>  2866
000

<210>  2867

<400>  2867
000

<210>  2868

<400>  2868
000

<210>  2869

<400>  2869
000

<210>  2870

<400>  2870
000

<210>  2871

<400>  2871
000

<210>  2872

<400>  2872
000

<210>  2873

<400>  2873
000

<210>  2874

<400>  2874
000

<210>  2875

<400>  2875
000

<210>  2876

<400>  2876
000

<210>  2877

<400>  2877
000

<210>  2878

<400>  2878
000

<210>  2879

<400>  2879
000

<210>  2880

<400>  2880
000

<210>  2881

<400>  2881
000

<210>  2882

<400>  2882
000

<210>  2883

<400>  2883
000

<210>  2884

<400>  2884
000

<210>  2885

<400>  2885
000

<210>  2886

<400>  2886
000

<210>  2887

<400>  2887
000

<210>  2888

<400>  2888
000

<210>  2889

<400>  2889
000

<210>  2890

<400>  2890
000

<210>  2891

<400>  2891
000

<210>  2892

<400>  2892
000

<210>  2893

<400>  2893
000

<210>  2894

<400>  2894
000

<210>  2895

<400>  2895
000

<210>  2896

<400>  2896
000

<210>  2897

<400>  2897
000

<210>  2898

<400>  2898
000

<210>  2899

<400>  2899
000

<210>  2900

<400>  2900
000

<210>  2901

<400>  2901
000

<210>  2902

<400>  2902
000

<210>  2903

<400>  2903
000

<210>  2904

<400>  2904
000

<210>  2905

<400>  2905
000

<210>  2906

<400>  2906
000

<210>  2907

<400>  2907
000

<210>  2908

<400>  2908
000

<210>  2909

<400>  2909
000

<210>  2910

<400>  2910
000

<210>  2911

<400>  2911
000

<210>  2912

<400>  2912
000

<210>  2913

<400>  2913
000

<210>  2914

<400>  2914
000

<210>  2915

<400>  2915
000

<210>  2916

<400>  2916
000

<210>  2917

<400>  2917
000

<210>  2918

<400>  2918
000

<210>  2919

<400>  2919
000

<210>  2920

<400>  2920
000

<210>  2921

<400>  2921
000

<210>  2922

<400>  2922
000

<210>  2923

<400>  2923
000

<210>  2924

<400>  2924
000

<210>  2925

<400>  2925
000

<210>  2926

<400>  2926
000

<210>  2927

<400>  2927
000

<210>  2928

<400>  2928
000

<210>  2929

<400>  2929
000

<210>  2930

<400>  2930
000

<210>  2931

<400>  2931
000

<210>  2932

<400>  2932
000

<210>  2933

<400>  2933
000

<210>  2934

<400>  2934
000

<210>  2935

<400>  2935
000

<210>  2936

<400>  2936
000

<210>  2937

<400>  2937
000

<210>  2938

<400>  2938
000

<210>  2939

<400>  2939
000

<210>  2940

<400>  2940
000

<210>  2941

<400>  2941
000

<210>  2942

<400>  2942
000

<210>  2943

<400>  2943
000

<210>  2944

<400>  2944
000

<210>  2945

<400>  2945
000

<210>  2946

<400>  2946
000

<210>  2947

<400>  2947
000

<210>  2948

<400>  2948
000

<210>  2949

<400>  2949
000

<210>  2950

<400>  2950
000

<210>  2951

<400>  2951
000

<210>  2952

<400>  2952
000

<210>  2953

<400>  2953
000

<210>  2954

<400>  2954
000

<210>  2955

<400>  2955
000

<210>  2956

<400>  2956
000

<210>  2957

<400>  2957
000

<210>  2958

<400>  2958
000

<210>  2959

<400>  2959
000

<210>  2960

<400>  2960
000

<210>  2961

<400>  2961
000

<210>  2962

<400>  2962
000

<210>  2963

<400>  2963
000

<210>  2964

<400>  2964
000

<210>  2965

<400>  2965
000

<210>  2966

<400>  2966
000

<210>  2967

<400>  2967
000

<210>  2968

<400>  2968
000

<210>  2969

<400>  2969
000

<210>  2970

<400>  2970
000

<210>  2971

<400>  2971
000

<210>  2972

<400>  2972
000

<210>  2973

<400>  2973
000

<210>  2974

<400>  2974
000

<210>  2975

<400>  2975
000

<210>  2976

<400>  2976
000

<210>  2977

<400>  2977
000

<210>  2978

<400>  2978
000

<210>  2979

<400>  2979
000

<210>  2980

<400>  2980
000

<210>  2981

<400>  2981
000

<210>  2982

<400>  2982
000

<210>  2983

<400>  2983
000

<210>  2984

<400>  2984
000

<210>  2985

<400>  2985
000

<210>  2986

<400>  2986
000

<210>  2987

<400>  2987
000

<210>  2988

<400>  2988
000

<210>  2989

<400>  2989
000

<210>  2990

<400>  2990
000

<210>  2991

<400>  2991
000

<210>  2992

<400>  2992
000

<210>  2993

<400>  2993
000

<210>  2994

<400>  2994
000

<210>  2995

<400>  2995
000

<210>  2996

<400>  2996
000

<210>  2997

<400>  2997
000

<210>  2998

<400>  2998
000

<210>  2999

<400>  2999
000

<210>  3000

<400>  3000
000

<210>  3001
<211>  29
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Wild type glucagon

<400>  3001

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3002
<211>  42
<212>  PRT
<213>  Homo sapiens


<220>
<221>  mat_peptide
<222>  (1)..(42)
<223>  Gastric Inhibitory Polypeptide

<400>  3002

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Asp Trp Lys His Asn Ile Thr Gln 
        35                  40          


<210>  3003
<211>  30
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(30)
<223>  GLP-1(7-36) amidated

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  C-terminal amidation

<400>  3003

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  3004
<211>  31
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(31)
<223>  GLP-1(7-37)

<400>  3004

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg Gly 
            20                  25                  30      


<210>  3005
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3005

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10  


<210>  3006
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3006

Gly Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
1               5                   10      


<210>  3007
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3007

Lys Arg Asn Arg Asn Asn Ile Ala 
1               5               


<210>  3008
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3008

Lys Arg Asn Arg 
1               


<210>  3009
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3009

Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser Lys 
1               5                   10      


<210>  3010
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-263

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3010

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3011
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-402

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  Xaa can be any naturally occurring amino acid

<400>  3011

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Lys Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3012
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-403

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  3012

His Ser Gln Gly Thr Phe Ile Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  3013
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-404

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  3013

His Ser Gln Gly Thr Phe Ile Ser Asp Tyr Ser Lys Ala Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Ile Ala Trp Leu Met Asn Thr 
            20                  25                  


<210>  3014
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-405

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  3014

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  3015
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-395

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  3015

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3016
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-396

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  3016

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Asp Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3017
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-397

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  3017

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Ile His Gln Lys Glu Phe Val Asn Trp Leu Leu Ala Gln 
            20                  25                  


<210>  3018
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-398

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge between residues 16 and 20

<400>  3018

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3019
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-217

<400>  3019

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  3020
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-218

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<400>  3020

Tyr Xaa Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  3021
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-219

<400>  3021

Tyr Ala Pro Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  3022
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-220

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<400>  3022

Tyr Xaa Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Cys Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  3023
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-225

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge links Glu16 and Lys20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amine of Lys is attached to Ala-Ac-Cys(PEG), wherein the 
       Ac-Cys(PEG) is a Cys residue comprising an alpha amino group 
       capped with an acetyl group (CH3CO) and comprising a 40 kDa PEG 
       covalently attached to its side chain

<400>  3023

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3024
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-226

<400>  3024

Tyr Ala Pro Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Cys Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  3025
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-227

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Lactam bridge links Glu16 and Lys20

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amine of Lys is attached to Arg-Ac-Cys(PEG), wherein the 
       Ac-Cys(PEG) is a Cys residue comprising an alpha amino group 
       capped with an acetyl group (CH3CO) and comprising a 40 kDa PEG 
       covalently attached to its side chain

<400>  3025

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3026
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-228

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  PEG (40kDa) bound to Cysteine

<400>  3026

Tyr Ala Pro Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Cys Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Trp Leu Lys His Asn Ile Thr Gln 
        35                  40          


<210>  3027
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #29

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3027

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3028
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #30

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3028

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3029
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #34

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  3029

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  3030
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #36

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3030

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3031
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #37

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3031

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3032
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #44

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is DMIA

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3032

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3033
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #49

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3033

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3034

<400>  3034
000

<210>  3035
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #53

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3035

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Val Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3036
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #54

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3036

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Lys Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3037
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #61

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3037

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3038
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #62

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3038

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3039
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #63

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3039

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3040
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #64

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3040

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3041
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #65

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3041

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3042
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3042

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3043
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3043

His Xaa Gln Gly Thr Phe Thr Ser Lys Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3044
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3044

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3045
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3045

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3046
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3046

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3047
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3047

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3048
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3048

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3049

<400>  3049
000

<210>  3050
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3050

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3051
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3051

Tyr Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3052
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3052

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3053
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3053

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3054
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3054

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3055

<400>  3055
000

<210>  3056
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(20)
<223>  Linked via lactam bridge

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3056

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3057

<400>  3057
000

<210>  3058
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Linked via lactam bridge

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3058

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Glu Ala Ala Xaa Lys Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3059
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (17)..(21)
<223>  Linked via lactam bridge

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3059

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Glu Ala Ala Xaa Lys Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3060
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is 1-aminocyclopropane-1-carboxylate

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3060

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3061

<400>  3061
000

<210>  3062
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C14 acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3062

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3063
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3063

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3064
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C14 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3064

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3065
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C14 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Covalently bound to a PEG

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3065

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  3066
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3066

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3067

<400>  3067
000

<210>  3068
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3068

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3069
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3069

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3070
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3070

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3071

<400>  3071
000

<210>  3072
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3072

Tyr Xaa Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3073
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptid


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is 1-aminocyclopropane-1-carboxylate

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3073

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3074
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is 1-aminocyclopropane-1-carboxylate

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3074

His Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3075
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is 1-aminocyclopropane-1-carboxylate

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3075

Tyr Xaa Gln Gly Thr Phe Ile Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3076
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  3076

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  3077
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amiation

<400>  3077

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  3078
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3078

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3079
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptid


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3079

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3080
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3080

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3081
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3081

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3082
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3082

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3083
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3083

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3084
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3084

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3085
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptid


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3085

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3086
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3086

His Xaa Glu Gly Thr Phe Ile Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3087
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3087

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3088
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3088

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3089
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3089

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3090
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3090

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3091
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3091

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3092

<400>  3092
000

<210>  3093
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #29

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acid amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3093

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3094
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #30

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3094

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3095
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #34

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  3095

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  3096
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #36

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3096

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3097
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #37

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3097

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3098
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #44

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is DMIA

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3098

Xaa Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3099
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #49

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3099

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Met Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3100

<400>  3100
000

<210>  3101
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #53

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3101

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Val Lys Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3102
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #54

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3102

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Lys Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3103
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #61

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3103

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3104
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #62

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3104

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3105
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #63

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3105

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3106
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #64

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3106

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3107
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Analog #65

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3107

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3108
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3108

His Xaa Gln Gly Thr Phe Thr Ser Lys Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3109
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3109

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3110
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3110

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3111
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3111

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3112
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3112

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Arg Ala Lys Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  3113
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C14 acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3113

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3114
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3114

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3115
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C14 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3115

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3116
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C14 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3116

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Cys 
        35                  40      


<210>  3117
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C14 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3117

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3118
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3118

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3119
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amidation

<400>  3119

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  3120
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  C-terminal amiation

<400>  3120

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Arg Gly 
            20                  25                  30      


<210>  3121
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  d-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3121

His Ser Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3122
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3122

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3123
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3123

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3124
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3124

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3125
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3125

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3126
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3126

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3127
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3127

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3128
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptid


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via acidic amino acid spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3128

His Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Arg Ala Xaa Glu Phe Val Gln Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3129
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3129

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3130
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3130

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3131
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3131

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3132
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  C-terminal amidation

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3132

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Asp Thr 
            20                  25                  


<210>  3133
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  mt-261

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3133

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3134
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<223>  mt-278

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is Aib

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  Xaa is Aib

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  16 Carbon fatty acyl group covalently attached to Lysine

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3134

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3135
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-384

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3135

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3136
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  mt-384

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Acylated with a C16 fatty acyl group via dipeptide spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3136

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3137
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3137

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3138
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3138

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3139
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covantly bound to a C16 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3139

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3140
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 succinoyl via a beta-Ala spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3140

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3141
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C18 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3141

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3142
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3142

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3143
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe is covalently bound to a C16 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3143

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3144
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  4-amino-Phe covalently bound to a C16 fatty acyl group via 
       gamma-Glu-gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3144

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Gly 
        35                  40      


<210>  3145
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Xaa is 4-amino Phe

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  4-amino Phe covalently bound to C16 succinoyl

<220>
<221>  MOD_RES
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3145

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Gly 
        35                  40      


<210>  3146
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  4-amino-Phe covalently bound to C16 fatty acyl group via 
       gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3146

His Xaa Gln Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3147
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound to C16 fatty acyl group via 
       gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3147

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3148
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  4-amino-Phe covalently bound to C16 fatty acyl group via 
       gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3148

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Xaa Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3149
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound to C16 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3149

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3150
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3150

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Lys Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3151
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3151

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Lys Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3152
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3152

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3153
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3153

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3154
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3154

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3155
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3155

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3156
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via a spacer comprising 
       an amido miniPEG acid and a gamma-Glu, wherein the amido miniPEG 
       acid has a structure {-N- CH2- CH2-[-O-CH2-CH2-]n-COO-}, wherein 
       n is 2

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3156

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3157
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via spacer comprising 
       an amido miniPEG acid and a gamma-Glu, wherein the amido miniPEG 
       acid has a structure {-N- CH2- CH2-[-O-CH2-CH2-]n-COO-}, wherein 
       n is 4

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3157

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3158
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via spacer comprising 
       an amido miniPEG acid and a gamma-Glu, wherein the amido miniPEG 
       acid has a structure {-N- CH2- CH2-[-O-CH2-CH2-]n-COO-}, wherein 
       n is 8

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3158

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3159
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is 
       attached to two C16 fatty acyl groups, wherein each C16 fatty 
       acyl group is attached to the Lys spacer via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3159

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3160
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is 
       attached to two C16 fatty acyl groups, wherein each C16 fatty 
       acyl group is attached to the Lys spacer via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3160

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3161
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12 fatty acyl group, which is covalently 
       bound to a gamma-Glu spacer, which is covalently bound to a C16 
       fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3161

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3162
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3162

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3163
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Sulfur of Cys is S-alkylated with -C(COO)H(CH2)13CH3

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3163

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys Gly 
        35                  40      


<210>  3164
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Lys covalently bound to Cys, the sulfur of which is S-alkylated 
       with -C(COO)H(CH2)13CH3

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3164

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3165
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to gamma-Glu, which is bound to Cys, the sulfur 
       of which is S-alkylated with -C(COO)H(CH2)13CH3

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3165

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3166
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is covalently bound to gamma-Glu, 
       which is covalently bound to C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3166

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3167
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys spacer, which is bound to gamma-Glu, 
       which is bound to C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to SEQ ID NO 167 via Cys spacer which is 
       disulfide bonded to a 2nd Cys, which the 2nd Cys is bound to Lys 
       at position 40 of SEQ ID NO 167 and is bound to gamma-Glu, which,
       in turn is bound to C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3167

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3168
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is bound to gamma-Glu, which is 
       bound to C16 fatty acyl group and the sulfer of the Cys is 
       thioether linked to a peptide of SEQ ID NO: 231 via Lys at 
       position 40

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3168

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3169
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is bound to gamma-Glu, which is 
       bound to C16 fatty acyl group, and the sulfur of the Cys is 
       disulfide bonded to a 2nd Cys, which the 2nd Cys is bound to a 
       peptide of SEQ ID NO: 231 via Lys at position 40

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3169

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3170
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3170

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3171
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C8 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3171

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3172
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C12 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3172

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3173
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Covalently bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C14 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3173

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3174
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covantly bound to PEG

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3174

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Cys 
        35                  40  


<210>  3175
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C14 succinoyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3175

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3176
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3176

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3177
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Asp of Glu

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is absent or is Gly (e.g. when position 10 is not Tyr) or is 
       an amino acid covalently bound to a C10-C26 acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Optionally present, when residue at position 40 is an amino acid 
       covalently bound to C10-C26 acyl or alkyl group, Xaa is Gly

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3177

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Xaa Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser Xaa Xaa 
        35                  40      


<210>  3178
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is absent or is Gly (e.g. when position 10 is not Tyr) or is 
       an amino acid covalently bound to a C10-C26 acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  Optionally present, when residue at position 40 is an amino acid 
       covalently bound to C10-C26 acyl or alkyl group then Xaa is Gly

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3178

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Xaa 
        35                  40      


<210>  3179
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3179

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3180
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(29)
<223>  At least one amino acid is an amino acid covalently bound to a 
       C10 to C26 acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Lys or Tyr

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Thr or Gly

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3180

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Asp Xaa 
            20                  25                  


<210>  3181
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Lys covalently bound to a C10-C26 acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3181

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Leu Asp Xaa 
            20                  25                  


<210>  3182
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3182

Gly Pro Ser Ser Gly Arg Pro Pro Pro Ser 
1               5                   10  


<210>  3183
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C12 to C18 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid, optionally, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3183

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  3184
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently attached to a C12 to C18 
       acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, an alpha, alpha disubstituted amino acid or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3184

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3185
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently attached to a C10 to C26 
       acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3185

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  3186
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, alpha, alpha-disubstituted amino acid, or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3186

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  3187
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is an acidic, basic or hydrophobic amino acid, optionally, 
       Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C12 to C18 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa can be any amino acid, optionally any amino acid other than 
       Gly, Pro or Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid, optionally, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3187

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  3188
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently attached to a C12 to C18 
       acyl or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, an alpha, alpha disubstituted amino acid or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3188

His Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3189
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is an acidic, basic or hydrophobic amino acid, optionally, is
       Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3189

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  3190
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, alpha, alpha-disubstituted amino acid, or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3190

His Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  3191
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C12 to C18 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Ala or a basic amino acid, optionally, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3191

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  3192
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C12 to C18 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, an alpha, alpha disubstituted amino acid or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3192

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3193
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is any amino acid, optionally, any amino acid other than Gly,
       Pro, and Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala or an acidic amino acid, optionally, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Ala, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3193

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  3194
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Gln or Gln analog or acidic, basic or hydrophobic amino 
       acid, optionally, is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr or an amino acid covalently bound to a C10 to C26 acyl
       or alkyl group

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu, alpha, alpha-disubstituted amino acid, or Lys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is Arg or Ala

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is a negative charged amino acid or a charge-neutral amino 
       acid, optionally, AIB or Gln

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Xaa is Leu, Ala, Nle, or Met

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Ala, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3194

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  3195
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(3)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(21)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (27)..(29)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3195

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Xaa Pro Pro Pro Ser 
        35                  


<210>  3196
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(3)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(21)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (27)..(29)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3196

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3197
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(3)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(21)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (27)..(29)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3197

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  3198
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(3)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (20)..(21)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (27)..(29)
<223>  Xaa can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminal amidation

<400>  3198

His Xaa Xaa Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Arg Xaa Ala Xaa Xaa Phe Val Gln Trp Leu Xaa Xaa Xaa 
            20                  25                  


<210>  3199
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3199

Glu Arg Ala Ala Gln 
1               5   


<210>  3200
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3200

Glu Arg Ala Ala Gln Asp 
1               5       


<210>  3201

<400>  3201
000

<210>  3202
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3202

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3203
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3203

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3204
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3204

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  3205
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3205

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Arg Pro Pro Pro Ser 
        35                  


<210>  3206
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via gamma-Glu-gamma-Glu 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3206

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  3207
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Lys spacer, wherein Lys spacer is bound via 
       the alpha amine to a gamma-Glu spacer, which is bound to a C16 
       fatty acyl group and Lys spacer is bound via the epsilon amine to
       gamma-Glu which is bound to a C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3207

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3208

<400>  3208
000

<210>  3209
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is bound
       to (1) C16 fatty acyl group via a gamma-Glu spacer and (2) C8 
       fatty acyl group via a gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3209

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3210
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is bound
       to (1) C16 fatty acyl group via a gamma-Glu spacer and (2) C12 
       fatty acyl group via a gamma-Glu spacer

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3210

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3211
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via side chain hydroxyl 
       of Tyr

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3211

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Tyr Gly 
        35                  40      


<210>  3212

<400>  3212
000

<210>  3213

<400>  3213
000

<210>  3214

<400>  3214
000

<210>  3215

<400>  3215
000

<210>  3216

<400>  3216
000

<210>  3217

<400>  3217
000

<210>  3218
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-345

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3218

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3219
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-346

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3219

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3220
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-347

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3220

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3221
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-348

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3221

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3222
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-349

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3222

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3223
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-350

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3223

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3224
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-351

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C14 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3224

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3225
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-352

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Covalently bound to 40kDa PEG via thioether made by reaction of 
       peptide with haloacetyl-activated PEG

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3225

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Cys Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3226

<400>  3226
000

<210>  3227
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-361

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3227

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Val Asn Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3228
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  MT-364

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  Acylated with a C16 fatty acyl group

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3228

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Met Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3229
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3229

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Cys Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3230
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3230

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3231

<400>  3231
000

<210>  3232
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound a C16 fatty acyl group via spacer 
       comprising two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3232

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3233
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  4-amino-Phe covalently bound to a C16 fatty acyl group via spacer
       comprising two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3233

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Xaa Gly 
        35                  40      


<210>  3234
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  4-amino-Phe covalently bound to C16 fatty acyl group via spacer 
       comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3234

His Xaa Gln Gly Thr Xaa Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3235
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  4-amino-Phe covalently bound to C16 fatty acyl group via spacer 
       comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3235

His Xaa Gln Gly Thr Phe Thr Ser Asp Xaa Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3236
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  4-amino-Phe covalently bound to C16 fatty acyl group via spacer 
       comprising acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3236

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Xaa Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3237
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Covalently bound to a C16 fatty acyl group via spacer comprising 
       acidic residue

<220>
<221>  MOD_RES
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3237

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Lys Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3238
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Covalently bound to a C16 fatty acyl group via spacer comprising 
       acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3238

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Lys Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3239
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Covalently bound to C16 fatty acyl group via spacer comprising 
       acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3239

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3240
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Covalently bound to C16 fatty acyl group via spacer comprising 
       acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3240

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3241
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via spacer comprising 
       acidic residue

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3241

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3242
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via a spacer comprising 
       an amido miniPEG acid and an acidic amino acid, wherein the amido
       miniPEG acid has a structure {-N- CH2- CH2-[-O-CH2-CH2-]n-COO-}, 
       wherein n is 2

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3242

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3243
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via spacer comprising 
       an amido miniPEG acid and an acidic amino acid, wherein the amido
       miniPEG acid has a structure {-N- CH2- CH2-[-O-CH2-CH2-]n-COO-}, 
       wherein n is 4

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3243

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3244
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via spacer comprising 
       an amido miniPEG acid and an acidic amino acid, wherein the amido
       miniPEG acid has a structure {-N- CH2- CH2-[-O-CH2-CH2-]n-COO-}, 
       wherein n is 8

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3244

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3245
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is 
       attached to two C16 fatty acyl groups, wherein each C16 fatty 
       acyl group is attached to the Lys spacer via spacer comprising an
       acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3245

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3246
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a Lys spacer, wherein the Lys spacer is 
       attached to two C16 fatty acyl groups, wherein each C16 fatty 
       acyl group is attached to the Lys spacer via spacer comprising an
       acidic residue

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3246

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3247
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C12 fatty acyl group, which is covalently 
       bound to a spacer comprising an acidic residue, which is 
       covalently bound to a C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3247

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3248
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to a C16 fatty acyl group via acidic amino acid 
       spacer

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to a C16 fatty acyl group via spacer comprising 
       an acidic residue

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3248

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3249
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to an acidic residue, which is bound to Cys, the
       sulfur of which is S-alkylated with -C(COO)H(CH2)13CH3

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3249

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3250
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is covalently bound to an acidic 
       residue, which is covalently bound to C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3250

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3251
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys spacer, which is bound to an acidic 
       residue, which is bound to C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to SEQ ID 251 via Cys spacer which is disulfide 
       bonded to a 2nd Cys, which the 2nd Cys is bound to Lys at 
       position 40 of SEQ ID 251 and is bound to an acidic residue, 
       which, in turn is bound to C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3251

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3252
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is bound to an acidic residue, 
       which is bound to C16 fatty acyl group and the sulfer of the Cys 
       is thioether linked to a peptide of SEQ ID NO: 231 via Lys at 
       position 40

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3252

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3253
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Cys, which is bound to an acidic residue, 
       which is bound to C16 fatty acyl group, and the sulfur of the Cys
       is disulfide bonded to a 2nd Cys, which the 2nd Cys is bound to a
       peptide of SEQ ID NO: 231 via Lys at position 40

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3253

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3254
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via spacer comprising 
       two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3254

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3255
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via spacer comprising 
       two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3255

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3256
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via spacer comprising 
       two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3256

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3257
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to C16 fatty acyl group via spacer comprising 
       two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3257

His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Ala Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3258
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via spacer comprising an
       acidic residue

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3258

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  3259
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via spacer comprising an
       acidic residue

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3259

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Arg Pro Pro Pro Ser 
        35                  


<210>  3260
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Covalently bound to C16 fatty acyl group via spacer comprising 
       two acidic residues

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3260

His Xaa Gln Gly Thr Phe Thr Ser Asp Lys Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Gly 
        35                  40  


<210>  3261
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Covalently bound to Lys spacer, wherein Lys spacer is bound via 
       the alpha amine to an acidic residue spacer, which is bound to a 
       C16 fatty acyl group and Lys spacer is bound via the epsilon 
       amine to an acidic residue which is bound to a C16 fatty acyl

<220>
<221>  MISC_FEATURE
<222>  (41)..(41)
<223>  C-terminal amidation

<400>  3261

Tyr Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Gln Asp Phe Val Gln Trp Leu Leu Asp Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys Gly 
        35                  40      


<210>  3262

<400>  3262
000

<210>  3263

<400>  3263
000

<210>  3264

<400>  3264
000

<210>  3265

<400>  3265
000

<210>  3266

<400>  3266
000

<210>  3267

<400>  3267
000

<210>  3268

<400>  3268
000

<210>  3269

<400>  3269
000

<210>  3270

<400>  3270
000

<210>  3271
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3271

His Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Arg Ala Ala Gln Glu Phe Val Gln Trp Leu Leu Glu Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3272
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C16 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3272

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3273
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C18 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3273

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3274
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3274

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3275
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C22 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3275

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3276
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C16 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3276

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3277
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C18 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3277

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3278
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3278

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3279
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C22 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3279

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3280
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Amino group of Tyr is covalently bound to Sar-D-Lys, wherein 
       epsilon amino group of D-Lys is acylated with a C16 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3280

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3281
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Amino group of Tyr is covalently bound to Sar-D-Lys, wherein 
       epsilon amino group of D-Lys is acylated with a C18 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3281

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3282
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Amino group of Tyr is covalently bound to Sar-D-Lys, wherein 
       epsilon amino group of D-Lys is acylated with a C20 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3282

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3283
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Amino group of Tyr is covalently bound to Sar-D-Lys, wherein 
       epsilon amino group of D-Lys is acylated with a C22 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3283

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3284
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C16 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3284

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3285
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C18 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3285

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3286
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein the epsilon amino group of the D-Lys is acylated with a 
       C20 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3286

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3287
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein the epsilon amino group of the D-Lys is acylated with a 
       C22 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3287

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3288
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C16 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3288

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3289
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C18 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3289

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3290
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3290

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3291
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C22 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3291

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3292
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3292

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3293
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Amino group of 4-amino-Phe is covalently bound to Lys, wherein 
       the epsilon amino group of the Lys is acylated with a C16 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3293

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3294
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Amino group of 4-amino-Phe is covalently bound to Lys, wherein 
       the epsilon amino group of the Lys is acylated with a C18 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3294

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3295
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Amino group of 4-amino-Phe is covalently bound to Lys, wherein 
       the epsilon amino group of the Lys is acylated with a C20 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3295

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3296
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Amino group of 4-amino-Phe is covalently bound to Lys, wherein 
       the epsilon amino group of the Lys is acylated with a C22 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3296

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3297
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein the epsilon amino group of the D-Lys is acylated with a 
       C16 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3297

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3298
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein the epsilon amino group of the D-Lys is acylated with a 
       C18 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3298

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3299
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein the epsilon amino group of the D-Lys is acylated with a 
       C20 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3299

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3300
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein the epsilon amino group of the D-Lys is acylated with a 
       C22 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3300

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3301
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Lys, wherein 
       the epsilon amino group of the Lys is acylated with a C16 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3301

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3302
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Lys, wherein 
       the epsilon amino group of the Lys is acylated with a C18 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3302

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3303
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Lys, wherein 
       the epsilon amino group of the Lys is acylated with a C20 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3303

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3304
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Lys, wherein 
       the epsilon amino group of the Lys is acylated with a C22 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3304

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3305
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C16 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3305

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3306
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C18 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3306

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3307
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3307

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3308
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C22 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3308

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3309
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C16 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3309

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3310
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C18 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3310

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3311
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3311

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3312
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C22 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3312

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3313
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C16 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3313

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3314
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C18 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3314

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3315
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3315

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3316
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C22 fatty
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3316

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3317
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Epsilon amino group of Lys is covalently bound to Lys, wherein 
       epsilon amino group of the Lys is acylated with a C16 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3317

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3318
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Epsilon amino group of Lys is covalently bound to Lys, wherein 
       epsilon amino group of the Lys is acylated with a C18 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3318

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3319
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Epsilon amino group of Lys is covalently bound to Lys, wherein 
       epsilon amino group of the Lys is acylated with a C20 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3319

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3320
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Epsilon amino group of Lys is covalently bound to Lys, wherein 
       epsilon amino group of the Lys is acylated with a C22 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3320

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3321
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amino group of Lys is covalently bound to Lys, wherein 
       epsilon amino group of the Lys is acylated with a C16 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3321

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3322
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amino group of Lys is covalently bound to Lys, wherein 
       epsilon amino group of the Lys is acylated with a C18 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3322

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3323
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amino group of Lys is covalently bound to Lys, wherein 
       epsilon amino group of the Lys is acylated with a C20 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3323

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3324
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amino group of Lys is covalently bound to Lys, wherein 
       epsilon amino group of the Lys is acylated with a C22 fatty acyl 
       group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3324

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3325
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3325

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3326
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3326

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3327
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3327

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3328
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3328

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


<210>  3329
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20-C28 
       fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3329

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3330
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20-C28 
       fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3330

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3331
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Amino group of Tyr is covalently bound to Sar-D-Lys, wherein 
       epsilon amino group of D-Lys is acylated with a C20-C28 fatty 
       acyl group

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3331

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3332
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20-C28 
       fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3332

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Phe Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3333
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20-C28 
       fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3333

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Lys Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3334
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is 4-amino-Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Amino group of 4-amino-Phe is covalently bound to Sar-D-Lys, 
       wherein the epsilon amino group of the D-Lys is acylated with a 
       C20-C28 fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3334

Phe Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Phe Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3335
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20-C28 
       fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3335

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3336
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20-C28 
       fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (39)..(39)
<223>  C-terminal amidation

<400>  3336

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  3337
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is AIB

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Epsilon amino group of Lys is covalently bound to Sar-D-Lys, 
       wherein epsilon amino group of D-Lys is acylated with a C20-C28 
       fatty acyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  C-terminal amidation

<400>  3337

Tyr Xaa Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys 
1               5                   10                  15      


Gln Ala Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser Lys 
        35                  40  


